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PREFACE 
The study to be presented here was conducted in the Merwede Hospital in 
Dordrecht. This hospital has a regional function and accommodates 
normal and advanced diagnostic facilities. Some of them are so 
specialized that patients from the whole region come to the hospital for 
examination. 
Why were the conditions at this particular hospital favourable for this 
study? In a large ophthalmological center, like the Eye Hospital in 
Rotterdam, the patient population often differs from that encountered in a 
general hospital. In the former, patients with early signs of diabetic 
retinopathy will be few and far between. Therefore, an ophthalmological 
department in a general hospital is a more suitable location for studying 
the early features of diabetic retinopathy. Since 1981 the author has 
worked as an ophthalmologist at the Merwede Hospital where he is 
provided with electrodiagnostic facilities. It was also 1981 that Bert 
Groeneweg was appointed as a physicist at the same hospital. He 
developed the software for an interdisciplinary electrodiagnostic 
department, along with the neurologist Pjotr Carbaat. A central computer 
system was installed for the averaging, storage and processing of 
information. Furthermore, the laboratory assistants attached to the 
neurophysiological department have become familiarized with methods 
for measuring small physiological signals applying rather complicated 
equipment. These assistants are also able to perform the visual 
electrodiagnostic tests. The consultant specialized in internal medicine, 
Bas van Ouwerkerk, cooperated in the study from the very start. His 
special interest has been endocrinology and diabetics which has proved 
to be a favourable condition for the selection of patients according to the 
protocol. The classical elektroretinographical examination methods were 
installed and technically completed between 1981 and 1984. On 
completion plans were made for a research project in collaboration with 
Professor van Lith of the Erasmus University Rotterdam, based at the 
electrodiagnostic department of the Eye Hospital in Rotterdam. In this 
medical institution Professor Henkes was one of the first to apply visual 
electrophysiology for clinical purposes. Among others he carried out 
extensive investigations on the electrophysiology of vascular 
disturbances of the retina. This original work led to the basic interest for 
9 
clinical application of electrodiagnostics in the diabetic retinopathy 
patient. 
The basis for my interest in visual electrophysiology was founded during 
my training period being a resident in the Eye Hospital. The close 
cooperation of the ophthalmological, internal and neurological 
departments together with the presence of advanced electrophysiological 
research facilities served to create the conditions which made the present 
study possible. 
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CHAPTER 1 
GENERAL CONSIDERATIONS AND 
A REVIEW OF THE LITERATURE 
1.1 Main features of diabetic retinopathy 
Patients with diabetic mellitus may develop diabetic retinopathy during 
the course of the disease. In order to study the electrophysiological 
characteristics of diabetic retinopathy, it is important to recognise the 
natural course of the disease in all its various manifestations and to 
classify the main features into the non-proliferative and proliferative 
types, as the prognosis will differ according to these two types (Davis, 
1974). These features are summarized in table 1 (Murphy and Patz in 
Little et aL, 1983). 
Table 1-1. Features of diabetic retinopathy 
Non-proliferative (background) retinopathy 
Simple background retinopathy 
~croaneurysms 
Dot and blot haemorrhages 
Hard exudates 
(Macular edema) 
Preproliferative retinopathy 
Beaded veins 
Soft exudates 
IRMAs (see 1.2.2 ) 
(Extensive intraretinal haemorrhages) 
Proliferative diabetic retinopathy 
Neovascularisation at the disc 
Neovascularisation elsewhere in the retina 
Fibrovascular proliferation 
Vitreous haemorrhage 
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1.2 Natural course of diabetic retinopathy 
The main structural changes in the pathological process of diabetic 
retinopathy occur at the level of the retinal capillaries, small arterioles 
and venules. From the evidence currently available, it appears that 
diabetic retinopathy is initiated by a breakdown of the inner blood retinal 
barrier, which could be histologically located at the opening of the 
endothelial tight junctions (Ishibashi et aL, 1980). The breakdown of the 
blood retinal barrier can be visualized by fluorophotometry (Cunha-V az, 
1981). Another main feature is capillary closure, seen clinically as tiny 
areas of non-perfusion by means of fluorescein angiography. This method 
contributes greatly to the diagnosis of microangiopathy. The capillary 
closures (drop outs) are often recognized as one of the earliest 
abnormalities in diabetic retinopathy (Klemen et aL, 1980). Capillary 
closure is associated with a dilatation of adjacent patent capillaries, which 
leads to capillary microaneurysms (de Venecia et al., 1976; Bresnick et 
aL, 1976). An even earlier feature is vasodilatation which is followed by 
capillary closure. Both features constitute one of the earliest 
ophthalmoscopical changes of the fundus in diabetic retinopathy 
(Kohner, 1975). The retinal capillary microaneurysm has become the 
hallmark of diabetic retinopathy, since its significance was rediscovered 
in 1943 by Ballantyne and Loewenstein (Duke-Elder and Dobree, 1967). 
1.2.1 In 1970, Dobree labelled the tiny changes such as microaneurysms, 
small haemorrhages and exudates as simple (background) retinopathies. 
They are often first seen in the posterior pole of the eyes and are generally 
symmetrically present. The tiny features seen in simple diabetic 
retinopathy may continue over a prolonged period, sometimes even 
extending several years (Davis, 1974). In some cases the retinopathy 
seems to improve spontaneously if judged by its ophthalmoscopical 
appearance (Oosterhuis et aL, 1979; Lauritsen, 1982). The explanation is 
to be found by studying the evolutionary stages of the microaneurysms. 
The feature of the microaneurysm begins with a tiny fluorescent spot in 
the immature stage which developes into a round regular spot, the mature 
microaneurysm. This stage is followed by an involuting process, showing 
an irregular fluorescent spot. In the end an atrophic microaneurysm is 
developed which does not stain with fluorescein (Bresnick et aL, 1983). 
1.2.2 It is accepted that diminished tissue oxygenation together with 
abnormal autoregulation may induce the early changes in the retinal 
vasculature and microcirculation (Grunwald et aL, 1984). Another early 
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sign of microcirculatory disturbances was recognised by Schulte in 1987. 
By means of fluorotachometry he measured a decreased capillary transit 
time in the early stages of diabetic retinopathy. It is suggested that the 
vasodilatation and beading of the venules are indicative of a persistent or 
a progressive form of the disease (Wilson et al., 1988). In accordance 
with Wolbarsht et al.'s hypothesis (1981) hypoxic tissue leads to 
dilatation of the venous capillaries and at the same time to an increase in 
transmural pressure as well as to a loss in the number of endothelial cells. 
This forms the instigation to increased permeability, haemorrhages and 
probably neovascularisation (Stefansson et al., 1983). The exact nature of 
the mechanism causing neovascularisation is still unknown, but it is 
assumed to be complex. Sebag and McMeel (1986) suggested that a 
retinaderived growth factor plays a role in the angiogenesis. 
1.2.3 Preproliferative diabetic retinopathy is a more advanced stage of 
diabetic retinopathy. It consists of cotton wool spots, beading of the 
veins, enlarged haemorrhages, some clusters of microaneurysms and 
intraretinal microvascular abnormalities. These microvascular 
abnormalities were labelled "IRMA" by Davis (1974). The IRMAs are 
generally considered to be preproliferative features and are still a sign of 
intraretinal retinopathy. Preproliferative diabetic retinopathy is a florid 
stage which progresses rapidly, often within a period of six month, to a 
proliferative retinopathy. 
1.2.4 In proliferative retinopathy, neovascularisations are usually first 
seen on or around the optic disc, sometimes earlier along the major veins 
on the retinal surface. Thereupon they may enter into the vitreous. In 
advanced proliferative stages they lead to glial proliferation and 
penetrated even further into the vitreous, often causing serious vitreous 
haemorrhages. 
Since the aim of the present study is to assess the role of 
electrophysiology in diagnosing early diabetic retinopathy, these more 
advanced proliferative forms of diabetic retinopathy will not be 
considered. 
1.3 Prevalence of diabetic retinopathy 
From cross-sectional studies of various diabetic populations it appears 
that the prevalence of diabetic retinopathy varies according to differences 
13 
in race, geographic location, observational techniques and duration of the 
disease (Constable et al., 1984; Danielsen et al., 1982; Jerneld and 
Algvere, 1984; Klein et al., 1984a and Kahn and Bradley, 1975). 
Unfortunately enough, no study representing the Dutch situation is as yet 
available. Assuming in this respect that the English situation does not 
differ greatly from the situation in the Netherlands, the English data 
presented by Kritzinger et al. (1984) give a good impression of what we 
may expect to occur in the Netherlands. In England the prevalence of 
diabetic retinopathy in the diabetic population runs at approximately 
30%. This estimate has been confirmed in the Netherlands by a small-
scale study in a local area of the Netherlands, carried out by Verhoeven 
(1989). He found a prevalence of 35% diabetic retinopathy among the 
non-insulin receiving group; of these retinopathies 40% was not found in 
the general practitioner's records. In a recent report Polak and Casparie 
(1989) give an estimate for the prevalence of diabetic retinopathy in the 
Netherlands based on various parallel studies, comprising 60 to 80 
thousand patients. In the studies concerning early diabetic retinopathy 
stereoscopic fundus photographs provide more detailed information than 
ophthalmoscopic examinations; resulting in a higher prevalence in 
photographic studies (Moss et al., 1985). 
Jerneld and Algvere (1986) performed a photographically controlled 
study concerning insulin treated patients. They found a prevalence of 
56% retinopathy for patients on the Island of Gotland with the onset of 
diabetes under the age 40, 18% of which consisted of proliferative 
retinopathy. For the group with onset of diabetes over the age of 40 the 
prevalence of all kinds of retinopathy together was 40%, including 8.1% 
proliferative retinopathy. Generally speaking, the longer the diabetic 
disease lasts the greater the prevalence of all kinds of retinopathy. Kahn 
and Bradley (1975) as well as Constable et al. (1984) emphasize in their 
studies the overwhelming importance of the effect of duration and age on 
the prevalence of diabetic retinopathy. They suggest to use multiple 
regression analysis to control this effect when studying other factors in 
relation to diabetic retinopathy. The effect of duration was demonstrated 
clearly in the Wisconsin epidemiological study by Klein et al. (1984b). 
For the age group with onset of diabetes over the age of 30 the authors 
found in the case of the insulin-receiving patients, a prevalence of 38% 
retinopathy after the diabetes had lasted five years, gradually increasing 
to 89% after a period of 25 years. For the non-insulin receiving patients' 
group the prevalence was 25% after 5 years and 58% after 25 years 
respectively. In a parallel study the age group with onset of diabetes 
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under the age of 30 showed a prevalence of 25% after five years gradually 
increasing to 97% after 25 years (Klein et aL, 1984c). Only the insulin 
taking patients, approximately 85% of this group, were examined. Based 
on incidence data, Klein et al. (1989) calculated sample size 
requirements. These estimates are highly useful in clinical trials when 
aiming at investigating the effect of (new) medicaments on diabetic 
retinopathy. 
1.4 Metabolic influences 
The influence of a careful metabolic control of the hyperglycemia on 
diabetic retinopathy has been described in numerous studies. A review of 
these studies was published by Caird in 1974. He emphasises the positive 
effect of good metabolic control. The well-known long term prospective 
study carried out by Pirart (1978) reports less retinopathy, neuropathy 
and nephropathy in patients with a good control of their blood sugars in 
the course of 25 years than in those showing a poor metabolic control. 
It might be that only the earlier stages of diabetic retinopathy are truly 
improved by thoroughly kept normoglycemia (Frank, 1984). Reversily 
intensified insuline treatment may in some cases cause progress of the 
non-proliferative diabetic retinopathy (Lauritzen et al., 1983; 
Dahl-J!Zirgensen et al., 1985 ). A generally accepted though not proven 
hypothesis says that in the very early stages of retinopathy the Continuous 
Subcutaneous Insulin Treatment (CSIT) will decrease the progression of 
the retinopathy. After treatment with CSIT Hooymans (1986) observed a 
slight improvement in five out of 35 patients with a simple diabetic 
retinopathy. The National Health Institute (USA) has designed a major 
prospective study. This study is meant to provide answers to the questions 
of how and in what stage a strict metabolic control of the diabetes will 
influence the progression or amelioration of pre-existent retinopathy 
(DCCT study group, 1987). 
There are several risk factors influencing diabetic retinopathy - high 
blood pressure being the best known- which aggravate the disease (Klein 
et al., 1984b and c). In 1985 Shorb reported three cases with severe iron 
deficiency anaemia. These patients had a rapid progression from a mild 
diabetic retinopathy to a severe proliferative phase. 
The influence of pregnancy on diabetic retinopathy was discussed by 
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Ohrt in 1984. This study deals with the reversibility of retinopathic 
changes in the postpartum period. 
Other aspects, such as an increased intake of unsaturated fatty acids, have 
a favourable influence on the natural course of the diabetic retinopathy 
(Houtsmuller et al., 1980 ; Howard-Williams et al., 1985). The role of 
alcohol as another risk factor in the genesis of the diabetic angiopathy is 
a subject that requires further investigation (Young et al., 1984). 
1.5 Electrophysiology of the eye 
The electrophysiology of the visual system deals with the measurement 
of electrical signals in relation to various light stimuli on the eye. Three 
major techniques can be distinguished, viz. the visual evoked potentials 
(VEP), the electro-oculogram (EOG) and the electroretinogram (ERG). 
1.5.1 The VEPs are the electrical cortical responses to visual stimuli. 
Flashes of light or chequerboard patterns are used. These responses can 
be led off by electrodes positioned in the occipital region of the scalp. 
Repeated stimuli have to be used in order to detect them within the 
background of the electro-encephalogram (EEG). The VEPs are not a 
subject of the present study. 
1.5.2 The EOG measures the potential difference between the anterior 
and posterior pole of the eye. This dipole consists of a positive polarity at 
the cornea compared to a negative polarity at the posterior pole of the 
eye. In ophthalmology the increase of this standing potential to light 
adaptation is mainly used. It reflects the activity of the deep rather than 
that of the superficial retinal layers. The EOG is of less significance for 
the aim of this study, as diabetic retinopathy is predominantly a disease 
of the superficial retinal layers. 
1.5.3 The ERG represents the electrical reaction of the retina elicited by 
visual stimuli. This electrical response is led off by means of an active 
electrode at the cornea, to which a contactlens electrode is usually applied 
with a reference electrode at the earlobe. The ERG consists of various 
components, of which the three basic ones were originally designated PI, 
PIT, and PHI by Granit in 1933. The ERG basically consists of a biphasic 
response, a negative a-wave from the receptors (PHI), followed by a 
positive b-wave (PH) originating in the bipolar cell layer. The late 
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c-wave (PI) is not always seen. It is a repolarisation potential of the 
pigment epithelium and is hardly ever applied for clinical purposes. Later, 
other components were discovered, the early receptor potential (ERP) by 
Brown and Murakami (1964) and the four small wavelets at the ascending 
limb of the b-wave named Oscillatory Potentials (OPs) by Cobb and 
Morton (1953). The OPs are disturbed in early stages of diabetic 
retinopathy, consequently they are the major subject of this study (figure 
1-1). 
In the case of the ERG responses their waveforms are expressed by the 
peak amplitudes in microvolts and by the peak latencies in milliseconds. 
The peak latency is also called implicit time. 
The origin of the separate components has been the subject of many 
experimental animal studies. They have recently been summarized by 
Dowling (1987). The a-wave represents photoreceptor activity (Brown, 
1968; Miller and Dowling, 1970). The b- wave is located in the Miiller 
cell which extends cross-sectional over a substantial part of the retina 
(Dowling, 1987). The origin of the OPs are not yet fully understood and 
will be discussed separately. 
Bs 
50 msec 
Fig. 1-1: Scheme of ERG components. This drawing depicts the time relations 
among some of the best-known components in the human ERG. The 
following components can be seen: the early receptor potential 
(ERP), the photopic and scotopic a-waves (Ap and As), the photopic 
and scotopic b-waves (Bp and Bs), the oscillatory potentials (OPs) 
and the c-wave. 
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The classical ERG as obtained by luminance stimuli of large retinal areas 
can be separated into a rod-dominated and a cone- dominated response by 
applying light stimuli of various luminances and colours . The rods have 
a maximum sensitivity for blue light near 510 nm and cones for yellow-
green light near 555 nm (Krill, 1972). Apart from luminance stimuli, 
usually elicited with a Ganzfield stimulator, a patterned stimulus can be 
applied. For clinical purposes, usually a checkerboard stimulus is applied 
in a reverse way or as a pattern presentation stimulus. The so called 
Pattern ERG (PERG) is strongly cone driven (Hess and Baker, 1984) and 
is possibly generated by the retinal ganglion cells (Fiorentini et al., 1981). 
1.6 Electrophysiology and diabetic retinopathy 
A short historical review will be given concerning the clinical 
applicability of the ERG in diabetic retinopathy. 
The studies ofKarpe et al. (1958) and Jacobson (1960) report that diabetic 
retinopathy does not affect the a- and b-wave amplitudes of the ERG until 
the disease has reached an advanced stag~. In the same study Karpe 
mentions supranormal ERG b-waves in some diabetic retinopathy 
patients. The supranormal ERGs were similar to those seen in venous 
stasis retinopathy. Probably, however, the "supranormal" amplitude is 
caused by an increase in a-wave amplitude (Speros and Price, 1981). In 
the late stage of diabetic retinopathy, particularly in the advanced 
proliferative forms, the b-wave implicit time increases and later on the 
amplitude decreases. This is followed by alteration of the a-wave (Li et 
al., 1985). 
In 1962, Yonemura et al. proved the clinical significance of the OPs 
elicited by a strong single flash. It appears that the diminution of the OPs 
occurs prior to the stage in which retinal destruction is extensive enough 
to diminish the b-wave amplitude. The extent of the Muller cell (1.5.3) 
and its dominant role in the b-wave generation might explain why the 
b-wave is not as sensitive as the OP to retinal capillary ischaemia is 
(figure 1-2) (Dowling, 1987). In these early clinical studies the 
correlation between the seriousness of the retinopathy and the reduction 
of the amplitude of the OPs remained uncertain. 
In 1966, Simonsen found the OPs to be hypernormal in diabetic patients 
without visible retinopathy. In the same study he found reduced OPs in 
eyes with simple retinopathy. The studies of Algvere (1968) and 
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Gjotterberg (1974) confirmed the reduction of the OP amplitudes. 
Furthermore, they established that in later stages and especially in the 
proliferative stage of diabetic retinopathy the a- and b-wave are also 
diminished. Galloway et aL (1972) paid special attention to the early 
stage of diabetic retinopathy and found normal OPs in a considerable 
proportion of such cases. More data concerning the relationship between 
OP amplitude and the severity of the retinopathy were presented by 
Bresnick and Palta (1987a), Hennekes and Deschner (1984) and Wanger 
and Persson (1985). None of these investigators could establish OP 
amplitude reduction in diabetic eyes without any visible retinopathy. 
In 1981, Simonsen suggested that the OPs have predictive value. In this 
study 54% of the patients belonging to the subnormal group of OP activity 
developed a proliferative retinopathy within six to eight years, while 
from patients with normal OP activity this was only the case in 6% over 
the same period. More recently, this was confirmed by Bresnick and 
coworkers (1984, 1987b). They estimated a ten-times higher rate of 
progression within one to three years in the diabetic retinopathy group 
with reduced OP activity, when compared to the retinopathy group with 
normal OPs. Unfortunately, they did not give the duration of the diabetes 
for the separate groups, although we know from prevalence studies that 
duration and progression rates are important factors (Klein et al., 1989). 
1.6.2 Not only the OP amplitudes but also the temporal aspects may 
provide information in relation to diabetic retinopathy. 
Brunette and Lafond (1983) found, under photopic conditions, an 
increase in the implicit time of the OPs before the OP amplitudes were 
reduced in the early stages of retinopathy. Bresnick and Palta (1987c) 
made similar observations and found the implicit times of the second and 
third OP to be increased in established stages of retinopathy. They also 
compared the implicit time of the b-wave to a 30 Hz flicker with the OP 
amplitude reduction and found the latter less sensitive than the increase 
in implicit time of the b-wave in the established and advanced stages of 
retinopathy. 
1.6.3 The perimetric function has already presented a decrease of retinal 
sensitivity in patients with a non-proliferative diabetic retinopathy as was 
demonstrated with an octopus perimeter by Bell and Feldon (1984). This 
decrease in sensitivity often corresponds with capillary dysfunction as 
controled by fluorescein angiography. This relation, however, could not 
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always be established. Probably there are also other metabolic influences 
on the retinal function which can not be related to capillary non-perfusion 
alone (Sannita et al., 1988). 
1.6.4 As to the PERG, Arden et al. (1986) found an amplitude reduction 
in patients with a preproliferative diabetic retinopathy. He describes the 
amplitude reduction of the PERG to be more sensitive compared to the 
OP amplitude reduction. This observation, however, could not be 
confirmed by Coupland (1987) and Wanger and Persson (1985). They 
demonstrated the reverse, that the PERG is less sensitive than the OPs in 
background retinopathies. This means that the PERG reveals only 
additional information in the preproliferative stage of diabetic 
retinopathy. Probably the diabetic maculopathy is a precondition for 
abnormal PERGs, since mainly the central field contributes to the PERG 
(Schuurmans and Berninger, 1985). fu the present study the PERG is not 
tested, since this method is not assumed to be as sensitive as the OP 
measurement in the early stages of diabetic retinopathy and secondly for 
the practical reason that the test procedure became too extensive for the 
diabetic patients participating the study. 
1. 7 Origin of the Oscillatory Potentials 
Most observations performed to discover the ongm of the various 
components of the ERG are carried out on animals. Y onemura and Hatta 
(1966) studied the OPs in the frog and Yokoyama et al. (1964) in the 
rabbit. 
The OPs are of low amplitude in these animals. They were supposed to 
originate from structures in the inner nuclear layer. In primates Brown 
(1968) obtained relatively better developed OPs at the periferal retina in 
comparison with the much smaller foveal OP amplitudes. By 
experimental clamping of the retinal circulation and separate depth 
profile studies he located the OPs in the inner part of the retina. In 
monkeys, Ogden (1973) could separate the origin of the OPs from the 
b-wave and found their maximum activity at the level of the inner 
plexiform layer. 
The experiments on the clamping of the retinal circulation are indicative 
of the sensitivity of the OPs to disturbances of the retinal circulation 
(Hayreh, 1984). The case report on an arterial occlusion points in the 
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same direction (van der Torren et aL, 1988). Steinberg stated in his 
Friedenwald lecture (1987) that the mitochondria of the rods are 
especially sensitive to mild hypoxia. This may be due to the anatomical 
configuration, namely, the close packing of the inner segments and 
mitochondrial clustering in the rod inner segments. In these experiments 
the sensitivity to the choroidal circulation and retinal circulation were not 
separated. Another explanation may be that the circuit from the bipolar 
cell to the ganglion cell is extremely sensitive to hypoxia and to small 
disturbances in the glycolysis (Winkler, 1981; Steinberg, 1987). 
A major question in studying the OPs is whether the separate wavelets 
originate in the same structure and whether they will react similarly in 
pathological conditions. These questions are especially important in 
electrodiagnostics, since they determine, whether or not the OPs may be 
added up and expressed in one measure. 
Wachtmeister and Dowling (1978) supposed different neuronal origins 
for the separate wavelets which together are called the OPs. The first 
wavelet was believed to originate more proximately within the retina 
than the following OPs. Later on, however, Heynen and van Norren 
(1985) found similar current source density profiles of all OP components 
in monkeys. These authors demonstrated that the bipolar cells most likely 
elicit the OPs. Wachtmeister subscribed to their conclusion in a study 
carried out with these investigators (Heynen, Wachtmeister and van 
Norren, 1985). Based on these latter studies, it has been assumed for the 
present study that the OPs can be averaged and expressed on an equivalent 
basis in terms of power. Without undermining this assumption, it is also 
possible that other intraretinal structures may influence the OPs. Another 
possibility for their origin might be the interplexiform cell (IPC), which 
belongs to the amacrine cell system (figure 1-2). These IPCs are supposed 
to form a feedback circuit of the horizontal cell onto the bipolar cell 
terminals and to contain dopamine as a transmitter (Dowling, 1987). 
After Heynen's investigations (1985), pointing to the bipolar cell as the 
only origin of the OPs, Miyake et aL in 1988 posited a relation between 
the OPs of the parafoveal ERG and amacrine distribution. The arguments 
in favour of the influence of the amacrine cells on the generation of the 
OPs was also brought forward by Wachtmeister and Hahn in 1987. Since 
it is known that the retina contains dopaminergic neurons (Ehinger, 1982) 
and that the generation of the OPs can be influenced by a dopamine 
antagonist (Wachtmeister 1981a and b), the IPCs may also be responsible 
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Fig. 1-2: The cell types of the amacrine system (green), as viewed in a vertical 
section of the retina. Three types are drawn in: A: the amacrine cell, 
H: the horizontal cell, IP: the interplexiform cell. 
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for this effect (Dowling, 1987). The effect ofmetoclopramide (dopamine) 
on the Ganzfeld ERG was studied by Jaffe et al. (1987). He concluded 
that dopamine could even modulate the OP biogenesis in human retina. 
The neurotransmitter L-acetylcarnitine is another drug with cholinergic 
properties which can influence the OP peak-latencies in diabetic patients 
(Sannita et al., 1988). 
1.8 Electroretinogram in photocoagulated eyes 
Xenon and Argon photocoagulation has become an accepted treatment of 
proliferative diabetic retinopathy (DRSR group, 1978). The purpose of 
this therapy is to destroy a substantial proportion of the peripheral retina 
in order to diminish oxygen demand and consequently the stimulus to 
neovascularisation (Korner and Korner, 1988). Several investigators tried 
to evaluate the effect upon the retina produced by extensive 
photocoagulation by means of ERG recordings. Ogden et al. (1976), 
Liang et al. (1983) and Perlman et al. (1985) found considerable 
reductions in the a- and b-wave after panretinal photocoagulation. The 
reduction in these studies was comparable to the extent of the destruction 
of the retinal area. Gjotterberg and Blomdahl (1981) and Li et al. (1986) 
saw a better correlation when the photocoagulated area was located in the 
periphery than when it was located more centrally in the retina. 
In a study concerning the alteration of the OPs in diabetic retinopathy 
after photocoagulation of large retinal areas, Hennekes and Deschner 
(1984) demonstrated a slight increase of the OP amplitude among some 
of a group of 28 subjects. The authors took this to be a positive result 
arising from the treatment. Furthermore, they suggest that OP 
measurement provides prognostic value in relation to functional recovery 
after photocoagulation treatment. Their results are based on the 
measurement of the second OP, which is a difficult technique, since the 
second wavelet is often hardly recognizable in the advanced stages of 
diabetic retinopathy (chapter 4). 
1.9 Aim of the present study 
It is generally accepted that the ERG reflects retinal activity as a mass 
response and is widely used as an objective index of retinal function. As 
such it can also be applied to measure the retinal function in diabetic 
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retinopathy. From the previous review of the literature it is obvious that 
the conventional ERG can only detect diminished retinal function when 
visible retinopathy is present; these ERGs have no prognostic value. 
Whether the OPs may provide such information in the early stage of 
retinopathy can not definitely be answered as yet. In the preproliferative 
stage this correlation has been demonstrated by Simonson (1981) and 
Bresnick and Palta (1987). 
Until recently, the OPs were assessed by simple recognition of the 
separate wavelets without measuring them. Because of the difficulty in 
recognising the individual OP wavelets, the present study intends to 
develope an index that facilitates the distinction of the OPs from the 
a- and b-wave and provides a quantitative measure. 
The study is devided into three sections: 
1: Searching for an improvement in the quantification of the OPs. 
2: Applying the measurement technique in a representative population 
of diabetic patients. 
3: Comparing the new technique with methods applied up to now. 
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CHAPTER 2 
MEASUREMENT OF OSCILLATORY 
POTENTIALS 
A pilot study 
Partly published in: 
K. van der Torren,G. Groeneweg, G. van Lith (1988) 
Measuring oscillatory potentials: Fourier analysis 
Documenta Ophthalmologica 69: 153-159 
This chapter describes a new OF-recording technique by means of signal 
processing. The method was tested on a reference group and compared 
with the results obtained from patients with diabetic retinopathy. 
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2.1 Introduction 
Various techniques have been applied to detect and to assess the 
Oscillatory Potentials (OPs) of the electroretinogram (ERG). The early 
study carried out by Cobb and Morton (1953) revealed that the human 
ERG evoked by strong single light flashes produced several rhythmic 
wavelets superimposed on the ascending limb of the b-wave. In 1962, 
Yonemura et al. validated their clinical interest by merely observing these 
single flash responses. He found the OPs to be lowered or absent in 
diabetic retinopathy. 
In order to obtain a quantitative measurement Algvere (1968) used a 
short time constant isolating the wavelets from the b-wave. Later on, 
Stodtmeister (1973) attempted to improve this technique by introducing 
an analog filter. 
The disadvantage with these filtering techniques is the resulting time 
shift in the OPs. Furthermore, there is an existence of a substantial 
residual activity of the a- and b-wave. Miyake and Solish (1978) tried to 
calculate the individual amplitudes, applying a calculated midpoint 
technique with a computerized system. The sum of the amplitudes was 
the measure for the OP activity. 
Also temporal aspects had the interest of various investigators (Kojima 
and Zrenner, 1978; Bresnick and Palta, 1987c; Lachapelle, 1988). 
Recognition of the separate waves is obligatory if peak latencies are to be 
measured. Often this appeared to be difficult in a clinical setting as 
pathological conditions and artifacts reduce the possibility of recognizing 
the wavelets separately. Special attention has been paid to Algvere and 
Westbeck's study (1972), in which Fourier analysis has been applied. For 
clinical practise this method was further developed in this study. 
Furthermore, Wachtmeister's recommendations (1973) concerning the 
luminance of the stimulus and a stimulus interval of 30 sec were used 
from the outset. Later on the stimulus interval was increased to favour the 
scotopic component as described in chapter 3.1.2. 
2.2 Apparatus and method 
2.2 .1 Hardware 
A PDP 11/23 computer (Digital Equipment) was used to store the ERG 
recordings. With this computer system a filtering procedure could be 
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selected and the filtered data could be compared with the unfiltered 
original recordings. 
2.2.2 Signal processing 
The high frequency OP signal was separated from the low frequency 
a- and b-waves by a Finite Impulse Response filter (FIR) of 110- 250Hz 
(Rabiner and Gold, 1975). This filter has the advantage of a linear phase 
characteristic and does not cause a phase shift in the OPs. From this 
filtered signal the implicit times as well as the amplitudes of the four OP 
wavelets could be measured separately (figure 2-1). These separate OP 
wavelets are labelled OP1, OP2, OP3 and OP4. The peak latencies 
(implicit times) are determined from the start of the light flash to the 
positive peak of the separate OP wavelets, using an automatic top 
detection. The amplitudes of the OP wavelets are measured from the 
minimum of the preceding negative trough to the maximum of the 
following positive wavelet. 
300 
A.JV 
75 
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§ mpl.time 6 c 2 
39 ms 
Fig. 2-1: Normal single flash ERG; white light flash of 10 J. 
Horizontal: time base. Vertical: microvolts. 
A) unfiltered signal, B) signal after finite impulse response filtering 
procedure (a = a-wave component), C) the implicit times of four 
OPs. 
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In the FIR filtered signal some residue from the a-wave is present, though 
there is a difference in frequency. Figure 2-lB presents this a-wave 
component (a) preceding the OPs. The frequency of this component may 
approach 90Hz, which can be near the lower frequencies of the OPs. The 
OPs are ranging from 123-170 Hz (chapter 2.4.2). Fourier analysis is 
applied to separate the OPs from this a-wave activity, yielding a 
frequency spectrum from which the OP-power is calculated. In figure 2-2 
the power densities at various frequencies are shown in the third column 
(FFT). A maximum is to be seen near 155 Hz. At this maximum the 
dominant frequency can be located. The OP-power is calculated from the 
power density spectrum around this dominant frequency using a floating 
window. The frequency range within this window is limited by the 
frequency at which the energy has half the intensity of the energy at the 
dominant frequency (figure 2-2, shaded area). 
2.2.3 Electroretinography 
The classical light flash ERG is measured under scotopic and photopic 
conditions using a Ganzfield stimulator (van Lith et al., 1973) and a 
Henkes contactlens electrode. The ERG signal is 2000 times enlarged by 
an amplifier developed by van Heuningen, Goovaerts and de Vries 
(1984 ). The amplified signal passes an analog filter between 0.5 and 500 
Hz after which the signal is sampled with a 12 bits AD (analog/digital) 
converter (ADF01 type DEC) at a frequency of 2000Hz. The digitized 
ERG signal is stored and processed using a separate procedure. 
The pupils have always been dilated beforehand. After 15 minutes of 
adaptation to the dark the scotopic ERG is elicited by means of blue light 
flashes of 1 Joule, the luminance of which is lowered by neutral density 
filters up to 2log units. This procedure is followed by the recording of the 
OPs with single white light flashes of increasing energy, viz. 1, 10 and 
80 J respectively. The 10 J flash stimulus is repeated three times to 
Fig. 2-2: Single white flash ERGs of a normal subject with intensities 1, 10, 
and 80 J. First column: the unfiltered signal; second column: the 
finite impulse response- filtered signal; third column: the fast 
Fourier transform (FFT) signal wherein the shaded interval is used 
to calculate the OP-power; fourth column: the OP-power in 
microwatts. 
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measure reproducibility. Between the registrations of the OPs a three 
minute interval is maintained. After the OP measurement the photopic 
responses are determined applying white light flashes of 1 J with a 
frequency of 2 Hz, superimposed on a bright blue background of 
6.5 cd/m2. 
2.2.4 Subjects 
The reference group consisted of 13 healthy subjects with 25 normal eyes 
matched up with the diabetic group in terms of age. The latter consisted 
of 12 patients with 23 eyes, varying in age between 30 and 65 (mean age 
41) and with diagnosed diabetes for at least seven years. The diabetic 
retinopathy patients had not been treated with xenon or argon coagulation 
before examination. By fluorescein angiography five patients in this 
group appeared to have non-perfusion areas or small neovascularisations. 
2.3 Results 
2.3.1 Power spectrum presentation 
Figure 2 gives the frequency spectrum of a single white flash ERG with 
OPs obtained from a normal subject with the three light flashes of 
increasing energy. In the unfiltered signal the increase of the OP 
amplitudes is evident. This is more clearly presented by the Fast Fourier 
Transform (FFT), the power of which can be expressed in one measure, 
the microwatt. 
The results of two diabetic patients are compared with those of a normal 
subject in figure 2-3. The reduced OP activity of the patient with early 
diabetic retinopathy is already visible in the original signal. In this patient 
only a few microaneurysmata and haemorrhages were visible by 
ophthalmoscopy, assessed as a simple diabetic retinopathy (chapter 1.1). 
Nearly absent OP activity is seen in the original recordings of the other 
patient with proliferative diabetic retinopathy in its early stage. This 
patient has small prepapillary proliferations, representing an advanced 
Fig. 2-3: Single white flash ERGs a normal subject (upper curve) and two 
diabetic patients: patient 1 with early diabetic retinopathy (middle 
curve), patient 2 with proliferative diabetic retinopathy (lower 
curve). 
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diabetic retinopathy and belonging to the proliferative form (chapter 1.1). 
Although the reduced activity can be seen in the original signal, the 
difference is more pronounced in the FFT; while the power provides the 
numerical value. 
Expressed in terms of power the results of the 10 J flash (figure 2-2) 
appeared to be most suitable when compared with those of the 1 and 80 J 
flashes. The OPs of the 1 J flash are not sufficiently pronounced, whereas 
in this pilot study the 80 J flash appeared to be too much of a burden for 
the patient. 
2.3.2 Power spectrum distribution 
The distribution of the power measurement obtained from the 25 normal 
eyes and the 23 diabetic eyes are presented in the bar diagram of figure 2-
4. For the horizontal axis a logarithmic scale has been chosen, since the 
values of the diabetic patients are relativily small compared to those of 
the reference group. From this figure one can deduce that the diabetic 
data are diminished. Most of them are well separated from the reference 
group. Ten of the twenty-three diabetic eyes had non-perfusion areas the 
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Fig. 2-4: Survey of results: normal subjects (dotted bars) and patients with 
diabetic retinopathy (shaded bars). Horizontal line, power in 
microwatts; vertical line, number of patients. 
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other ones varied from an early to a proliferative stage. There was at least 
a ten times difference between the power of the established diabetic 
retinopathy subjects and the power of the normal subjects, promising a 
power range wide enough to separate the various pathological stages of 
retinopathy. This was not performed in the pilot study but will be 
described in chapters 3 and 4. 
2.4 Discussion 
2.4.1 Computerized system 
The advantages of a computerized system have been briefly discussed by 
Miyake et al. (1978). The ERG storage and automatic top detection makes 
signal processing practicable. Kozak (1982) made us aware of the 
possibility of entering a second computation procedure after the digital 
filtering of the original signal. In the present study the computer system 
was a great asset in selecting the optimal filtering procedure as well as in 
selecting the frequency interval for the power measurement. 
2.4 .2 Selection of the frequency interval 
By isolating the OPs on a frequency basis, a measurement was introduced 
which takes into account not only the maximum OP energy at the 
dominant frequency, but also the distribution over the frequency domain. 
This is different from a selection on the basis of time only, which forms 
the basic principle for most of the clinically applied methods. By 
introducing the frequency in the OP measurement method more 
information on the characteristics of the OPs is obtained. 
Theoretically a fixed frequency interval for the OP-power calculation 
would be preferable, as the contribution from the foregoing a-wave to the 
power in a fixed interval is supposed to be more constant than in a floating 
interval. Therefore, we first opted for the procedure of calculating the 
power with a fixed interval from 123 to 170Hz. This choice was based on 
the average width of the area, in which OP activity could be observed in 
the FFT. To select the limits of lower and higher frequency for this fixed 
interval, the mean and standard deviation (SD) of the upper and lower 
frequencies was calculated. The mean was 135Hz for the lower and 160 
Hz for the upper frequency. The lower limit was obtained by reducing the 
lower frequency by twice the SD of 6 Hz, the upper by adding twice the 
SD of 5Hz. In this way an interval of 123 Hz to 170Hz was obtained for 
the fixed interval procedure. When applying this interval for calculating 
the power in the group of normal individuals, it proved impossible to 
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obtain a Gauss distribution for the reference group. For this reason we 
opted for a floating window. 
A normal Gauss distribution was obtained as long as the calculations 
were based on the dominant frequency with a floating window centered 
around this frequency and with a window aperture dependent on the 
curve width. When applying a floating window the spectrum width is 
taken into account. In this way it is possible to obtain extra information 
from the OP-power when the frequency spectrum of the OPs is broadened. 
This would not be possible if only the dominant frequency was calculated 
without a window. 
The dominant frequency of the diabetic patients will be further analyzed 
in the next chapter. 
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CHAPTER 3 
POWER MEASUREMENT OF THE 
OSCILLATORY POTENTIALS IN DIABETIC 
RETINOPATHY 
Partly published in: 
Torren van der K, Lith van G (1989). 
Oscillatory potentials in early diabetic retinopathy. 
Doc. Ophthalmol. 71: 375-379. 
In this chapter a description is given of the effect of diabetic retinopathy 
on OP-power. 
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3.1 Introduction 
3.1.1 OP measurement in diabetic retinopathy 
The notion that abnormalities of the OPs could be used as prognostic 
tools in diabetic retinopathy was put forward by Simonsen (1975). 
Various functions of the OPs, such as temporal aspects (Kojima and 
Zrenner, 1978; Bresnick and Palta, 1987c; Lachapelle, 1988) and 
amplitude summation (Algvere, 1968; Miyake et al., 1978) were studied 
in relation to the progression of retinopathy. The results of the methods 
applied in the foregoing studies do not resolve the question as to whether 
reduction in OP activity is a sign of an early stage of diabetic retinopathy. 
In the present study a quantitative method based on the frequency 
spectrum of the OPs is applied (chapter 2). Since dark adaptation has a 
substantial influence on the OPs, special attention has been paid to this 
topic (3.1.2). The sensitivity of the method has been tested by examining 
patients in the early stages of diabetic retinopathy. It is for this reason too 
that a special section has been devoted to the classification of diabetic 
retinopathy (3.1.3). 
3.1.2 Dark adaptation and OP measurement 
In order to obtain high OP responses Wachtmeister (1973 and 1987) 
advocates to register OP activity at the transition from scotopic to 
photopic vision. This can be achieved by presenting high energy light 
flashes (> 1 J) with a stimulus interval of 30 seconds (W achtmeister, 1973 
and 1987). 
Under scotopic conditions Peachy et al. (1987) observed similar OPs in 
rod monochromats and normals. Measured at the transition from photopic 
to scotopic vision, the OPs in the rod monochromats were markedly 
reduced. This finding suggests that under these conditions the OPs result 
primarily from the cone system. From the studies carried out by Gliem 
and Schulze (1966) as well as Frost Larsen et al. (1981) the sensitivity to 
dark adaptation appeared to be significantly reduced in the case of 
diabetic retinopathy. This reduction appeared to be progressive towards a 
proliferative stage. This finding is confirmed by the fluorescein 
angiographic studies ofNiki et al. (1984) as well as Shimizu et al. (1981). 
In both studies it is reported that examination of the mid-peripheral area 
is very important for the detection of early diabetic retinopathy. It is also 
this area where rod density is highest and where dark adaptation is 
predominantly determined (Sigelman and Ozanics, 1982, in Duane). In 
1988 Sieving and Nino studied the Scotopic Threshold Response (STR) 
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in the ERG and concluded that this response reflects post-receptor 
processing in the rods pathway. In a recent study Aylward (1989) 
describes the STR as a sensitive parameter to early diabetic retinopathy. 
A conclusion from these studies is that the dysfunction of the rod system 
is a characteristic of early diabetic retinopathy. 
For this reason recording OPs under scotopic conditions seems to be 
more commendable. It was King Smith et al. (1986) who made a clear 
distinction between scotopic and photopic OPs. His observations are 
often taken into consideration. 
To enhance the scotopic component a three minutes stimulus interval was 
applied in this part of the study instead of the 30 second interval 
advocated by Wachtmeister (1987). 
Another advantage of favouring the scotopic component is the frequency 
shift of the OPs to higher values as reported by Wachtmeister in 1973. 
This shift makes it easier to discern the OPs from the lower frequencies of 
a- and b-wave. 
3 .1.3 Classification of diabetic retinopathy 
As the aim of this study is to detect the role of OPs in early diabetic 
retinopathy, a special classification of the early stages was needed. 
The report on the classification of diabetic retinopathy by Haut et al. 
(1987) demonstrates clearly the advantages of a system based on 
fluorescein angiography. One of the generally applied systems is the 
Airlie House Classification (DRS group, 1981). In accordance to this 
classification, a four field photographic standard was chosen for the 
present study. However, since the Airlie House Classification is less 
adequate in discriminating the early stages of diabetic retinopathy, more 
specified criteria for the early signs have been introduced. 
The following studies influenced the choice of these criteria. The 
photographic classification system as presented by Nielsen (1984) 
specified the early signs of diabetic retinopathy in detail but did not take 
into account the additional information, which can be obtained from 
fluorescein angiography. The early signs, which are not ophthalmo-
scopically visible, were studied by Klemen et al. (1980) by means of an 
advanced fluorescein angiographic technique.This investigator found 
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capillary non-perfusion areas in 29% of the elderly and in 60% of the 
juvenile diabetic pre-retinopathies. A similar angiographic study relating 
to non-perfusion areas was presented by Niki et al. (1984), whereby 
abnormalities in the periphery were observed in only four of the 152 eyes. 
Therefore, the fact that these peripheral changes might be missed in the 
four field photographic standard as used in the present study does not 
pose a problem. The capillary non-perfusion areas are sometimes called 
dropouts. Actually, dropouts are caused by capillary closures, which are 
different from the non-perfused areas, caused by arteriolar closures. The 
latter sometimes showing cotton wool spots (Bresnick et al. in Little et 
al., 1983). Dropouts or, in other words, non-perfused capillaries did not 
add to the predictive value of his regression models (Bresnick and Palta, 
1987c). 
In early diabetic retinopathy the avascular fovea may be enlarged under 
fluorescein angiography, due to dropouts at the inner ring of the 
capillaries surrounding the fovea. In these cases, this enlarged avascular 
area is again surrounded by capillaries with enlarged dilatations 
Fig. 3-1: Fluorescein angiogram of the foveal area of the right eye. Increased 
visibility of some capillaries surrounding an enlarged avascular zone. 
This picture is called: "too good to be true". 
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(Bresnick et al. in Little et al, 1983). These two phenomena create the 
impression of an enlarged and more visible foveal area. These foveal 
changes are sometimes labelled "too good to be true" (figure 3-1). In the 
present study they could be observed in the first group of diabetic 
patients. 
3.2 Method 
3.2 .1 Diabetic classification 
The fundus photography was performed with a Topcon TRC-50 VT type 
camera. Both eyes of all the patients participating were photographed, 
followed by fluorescein angiography using four standard fields with a 
visual angle of 35 degrees and one central field with temporal extent of 
50 degrees. The four standard fields are :the optic disc area, the regions 
along the upper and lower temporal vessels, and a central area (figure 
3-2). Based on these pictures four groups of patients with diabetic 
retinopathy could be distinguished. 
Fig. 3-2: The four fields of fluorescein angiography. The photograph angle is 
35 degree for the fields 1 to 4, photographed in the first 50 seconds 
followed by the 50 degrees central field 
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Diabetic retinopathy groups 1-4; 
Group 1: No ophthalmoscopical visible diabetic retinopathy; 
Some microaneurysms are permitted, but no more than five 
for the cumulated area of the four standard photographs. 
Group 2: Early exudative diabetic retinopathy 
(non proliferative); 
Microaneurysms, some haemorrhages, exudates, capillary 
non-perfusion areas. 
Group 3: Preproliferative diabetic retinopathy; 
Scattered intraretinal haemorrhages, exudates, cotton wool 
spots, beaded veins, large dark blot haemorrhages, clusters 
of microaneurysms surrounding non-perfusion areas, 
IRMA's. 
Group 4: Proliferative diabetic retinopathy; 
Intraretinal and preretinal proliferations beginning 
proliferations on the optic disc. 
Group NS: Normal subjects. 
The patients were assigned to the diabetic classification before the 
electrodiagnostic procedure was performed. The assignment to the four 
categories was checked by a colleague specialised in fluorescein 
angiographic diagnostics. 
3.2 .2 Patients selection 
The reference group (NS) consisted of 27 healthy subjects matched for 
age with the 81 diabetic patients as far as this was possible. The age is 
slightly different distributed due to a practical problem; hospital staff was 
particularly easy to motivate when it came to finding normal subjects for 
the determination of the normal values. However, the mean and range of 
the parameter age for this group was smaller than that of the diabetic 
patients. The mean age of the reference group is 41.5 years with a range 
from 20 to 60, while that of the diabetic patients is 43.2 years ranging 
from 20 to 65 years. Taking group 1 separately, the mean age is 40. The 
age distribution of the entire diabetic group (1-4) and that of the reference 
group NS is given in figure 3-3. Group 1 is also shown separately since 
the OP-power data between this group and the reference group are also 
compared separately. 
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Fig. 3-3: Age distribution divided into classes at five year intervals. Upper 
recording: normal subjects (NS), middle: diabetic group 1 and lower: 
total of the four diabetic groups. 
In a recent paper by Sannita et al. (1988) it has been shown that OP 
amplitudes change with age. He found an increasing OP amplitude with a 
maximum at about 50 years of age, slowly decreasing thereafter. The 
effect of age on the OP-power of the diabetic groups and the reference 
group was tested separately by the Wald test which measures the 
significance of fixed effects and covariates. The age effect appears to be 
non significant. The 81 diabetic patients (42 male and 39 female) had 
been treated with insulin (65 out of 81) or with oral antidiabetics (16 out 
Table 3-1. Mean duration of diabetes per group of retinopathy 
Classification 
Group 1 
Group 2 
Group 3 
Group 4 
Mean 
in years 
12 
15 
15.5 
18 
41 
myopia of seven diopters; in the case of another patient, the ERG is 
computed from only one eye due to the presence of a cataract on the 
contralateral eye. None of the patients is known to have other eye 
diseases. In particular they were not suffering from glaucoma. These 
features are important, since it has been reported that the development of 
diabetic retinopathy is inhibited by high myopia and glaucoma (Becker, 
1981). Glaucoma may also decrease OP activity (Gur et al., 1987). 
Cataract will influence the degree of retinal illumination brought about 
by the stimulus. For these reasons patients with either of these 
abnormalities were barred from the study, except for the one with the 
myopia. Also patients with more general afflictions which might show 
possible side effects, such as established hypertensive or coronary heart 
disease, were excluded from the study. 
3.2.3 Electroretinographical method 
The classical light flash ERG, filtering procedure by finite impulse 
response filter (FIR) and power measurement were performed as 
described in chapter 2 t-- . The scotopic OPs were obtained by a 10 J 
single white light flash following the standard scotopic ERG with an 
additional three minute interval of dark adaptation before each flash. The 
dominant frequency of the FFf was noted separately. The photopic OPs 
were obtained from the averaged 1 J photopic ERG as described in 
chapter 2.2.3. 
For the detection of the classical ERG in diabetic patients the Henkes 
contact lens electrode has been recomended by Vey et al. (1979). In the 
first period of the study this contact lens sometimes produced photo-
electrical artefacts (figure 3-4) (Carr and Siegel, 1982). The frequencies 
of these artefacts were sometimes near or in the same interval as the OP 
frequencies. Other artefacts were probably caused by a shifting of the 
contact lens over the eye, due to discomfort and muscular spasm during 
the large dark-adaptative period. Other disadvantages of long 
examination procedures and shifting of the contact lens were corneal 
erosions as seen more often in the diabetic group, probably due to a 
decrease in the quality of the epithelium attachment to the basement 
membrane of the cornea (Azar et al., 1988). To avoid these problems 
during the study the circular inner curve of the contact lens was modified 
into an eliptic one by the Titmus contact-lens factory. 
42 
A 
30opvL 
25 msec. 
75pvL 
25 msec. 
B 
Fig. 3-4: Single flash responses with photoelectrical artefacts in the first milli-
seconds. The FIR filtered signal shows activity within the frequency 
area from 110-250 Hz. 
3.3 Results of OP-power measurement 
3.3.1 OP-power and diabetic retinopathy 
The frequency spectrum and calculated power of four patients, one from 
each of the specific diabetic groups, are given in figure 3-5 to serve as an 
example. Parallel to the increasing severity of the diabetic retinopathy, 
OP activity, expressed in OP-power, decreases gradually. The OP-power 
of the reference group and the four diabetic groups together ranged from 
29 to 153 microwatt and from 3 to 149 microwatt respectively. This 
indicates that the inter-individual OP-power data are spread over a wide 
range not only in the diabetic groups but also in the reference group. 
The mean of the OP-power and the standard deviation (SD) of the groups 
are given in table 3-2. The SD is large with respect to the mean of the OP-
power, which can be explained by the large variation range per individual 
and a relativily small sample size (N). The OP-power of the diabetics and 
normal subjects is worked out on a logarithmic scale, because it resulted 
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Fig. 3-5: Fast Fourier Transform ( FFT) and calculated power of a 10 Joule 
single white flash ERG in four diabetic patients, one from each 
group. 
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Table 3-2. Mean and SD of the OP-power in microwatts seperately for right 
and left eyes; N: Number of eyes. 
OD OS 
Classification Mean SD N Mean SD N 
NS 58.5 19.2 26 54.3 23.7 26 
Group 1 42.4 26.4 28 42.3 26.7 23 
Group 2 37.5 29.8 26 41.6 33.5 21 
Group 3 17.1 9.9 15 16.9 10.1 11 
Group 4 9.7 5.9 6 7.7 3.9 5 
in a better distribution in terms of the reference group (see chapter 2.4). 
This choice was confirmed by the statistical results. The correlation 
coefficient of the paired samples t-test is slightly higher with a 
logarithmic presentation (reproducibility, chapter 3.3.3). The 
measurement results of the OP-power per diabetic group are to be found 
in the bar diagram numbered figure 3-6. It appears that the OP-power is 
lower in diabetic group 1 than in the normal group. This means that the 
OP activity diminishes even before the appearance of diabetic 
retinopathy. The statistical estimates concerning the four diabetic groups 
and the reference group were calculated by a repeated measurement 
ANOVA with covariates (Statistical software program BMDP 5V 1988). 
The interdependent variable in this procedure is the logarithm of the OP-
power measured in microwatts for both eyes. The group factor is the 
factor between subjects (Beta) from the diabetic groups (1-4) and the 
reference group (NS). The factor within subjects represents the variation 
between the left and right eye and the covariate represents the age of the 
subject. Due to a number of values among the OP-power results which 
were missing, a maximum likelihood estimation method had to be 
applied. These results were missing for technical reasons, namely that 
some subjects had only one eye tested either OD or OS, whilst others had 
values rejected following the discovery of artefacts. During the research 
period the chance of obtaining such artefacts was reduced by remodelling 
the contact lens electrode as described before (3.2.3). Figure 3-3 presents 
an example of a very high response in the FIR filtered curve, caused by an 
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artefact. As one can see, this artefact is situated within the frequency 
range of the filter, being 110-250 Hz, and as a consequence it may also 
disturb the OP-power measurement. 
3.3 .2 Statistical estimates between the separate diabetic groups 
Table 3-2 gives the mean and standard deviation values of the OP- power 
for the two eyes seperately and for all groups. The irregularity in the 
number of patients per group (N-values) are a result of the fact that for 
some patients only one eye could be examined. The overall relation of the 
four diabetic groups on the OP-power of both eyes was statistically 
significant (p < 0.001), when tested with the repeated measurement 
ANOVA. Table 3-3 gives estimates of the factor Beta (the group variable) 
and of the reference group (indicated as group NS). The Beta coefficient 
for the group NS is set at zero. The coefficient decreases inversely with 
the severity of the diabetic retinopathy. Furthermore, the power 
calculation method reveals a statistically significant decrease of OP 
activity in diabetic patients without visible retinopathy, the p-value being 
0.004 for the difference between group 1 versus the NS group. The p-
values for the successive steps of the remaining groups are given in the 
right- t- hand column of table 3-3. The OP-power estimates of table 3-3, 
already present a clear reduction in OP activity at a stage in which no 
ophthalmoscopical changes were to be seen. As already explained, this 
does not necessarily imply the absence of diabetic retinopathy, since by 
using fluorescein angiography small changes can sometimes be seen 
(chapter 3.2.1). 
If in the estimates of table 3-4 the reference is set at 100% for the normal 
group (NS), then the OP-power of the first diabetic retinopathy group is 
65%, the second group 54% , the third group 26% and the fourth group 
17%. The estimates for the OP-power which were recalculated from the 
factor Beta are given in the right-hand column of table 3-4. These 
estimates are adjusted for left and right eye as a within-patient factor and 
for the age of the subject as a covariate. 
Fig. 3-6: Distribution in classes of the OP-power in log microwatts, the refer-
ence group and the diabetic group 1 , 2 and 4 (shaded bars oblique 
slanting to the right), group 3 shaded bars oblique slanting to the 
left. 
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NS= normals, I= diabetic group 1, II= diabetic group 2, III= diabetic 
group 3, IV= diabetic group 4. 
N 
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Table 3-3. Estimates of 13 coefficient from separated measurement ANOV A 
Classification 13 coefficient Level of significance 
NS 0 
f P ~ o.oo4 J Group 1 -0.42776 p < 0.001 
}P = 0.126 
Group 2 -0.61706 };<~.00~-
Group 3 -1.33517 }p = 0.051 
Group 4 -1.80226 
Table 3-4. Estimates of OP-power in percentages and in microwatts. 
Classification % J.lW 
NS 100 54.9 
Group 1 65 31.7 
Group 2 54 20.2 
Group 3 26 15.1 
3.3 .3 Reproducibility 
To test the reproducibility of the OP-power, the 10 J response was 
recorded three times, of which the first and the second were used for the 
OP-power calculation, the third response was only taken when an artefact 
was present in one of the other two recordings. The difference in OP-
power of the second response was statistically tested with a paired t-test 
and with the Wilcoxon matched pairs Signed-ranks test. Neither test 
indicated a difference on repeated measurement. Also the correlation 
coefficient (R), from the paired sample t test was calculated between the 
duplicate measurements, R being 0.887 for the OP-power and 0.920 for 
the corresponding logarithm values. This also implies that there was no 
displacement in the order of ranking. The correlation coefficient for the 
logarithm of the OP-power was slightly higher for both eyes which 
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designates a preference for this setting (chapter 2.4 and 3.3.1). One may 
conclude that there is a stable reproducibility for the individual OP-power 
measures. 
3.3 .4 Dominant frequency 
The dominant frequency of the FFT shifted to lower values, while the 
diabetic retinopathy increased in severity. Table 3-5 presents the mean 
and SD of the dominant frequency of the OPs for the right eye as recorded 
in all groups separately. The left eye showed similar values. The 
frequency shift to lower values was found to be statistically significant 
for the successive groups as tested by the Kruskal-Wallis 1-way ANOVA. 
This implies that the frequency can be considered as a parameter in 
addition to the implicit time (chapter 4.2.4) and the OP-power. 
3.3.5 Photopic OP measurements 
When applying the frequency spectrum method to measure the OPs of the 
photopic ERG, it appeared to be impossible at the time to separate the 
OPs from the foregoing a-wave by using Fourier analysis, as the 
frequencies of these two components are too close. The situation under 
photopic conditions is different from the one under scotopic conditions in 
that the OPs photopically do not present themselves as distinct peaks 
although they are clearly visible in the unfiltered and FIR filtered 
recordings. 
In those cases where a distinct interval could be obtained the mean 
frequency of the photopic OPs was 124Hz. In one third of the cases in 
Table 3-5. Mean and SD of the dominant frequency in Hz from the FFt for the 
rigt eye; N: number of eyes. 
Classification Mean SD N 
NS 148.2 5.8 26 
Group 1 142.4 5.8 28 
Group 2 141.6 5.7 26 
Group 3 137.2 6.1 15 
Group 4 135.6 6.8 7 
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which OPs could not be detected by Fourier analysis, the frequency was 
near or below 100 Hz. 
3.4 Discussion 
The diagnostic value of the OPs in diabetic retinopathy has been 
discussed in the past by several authors. Yonemura et al. (1962) made us 
aware of the clinical applicability of the OPs. They observed that in cases 
with simple retinopathy the a- and b-wave were not disturbed, whereas 
the OPs could be greatly diminished or might even disappear. In the 
present study the OP activity of the diabetic group 2 was already reduced 
to 54% of the reference group (table 3-4) confirming the observations of 
Yonemura and Kawasaki (1978), since the patients they examined could 
be classified as belonging to diabetic group 2 (chapter 3.1.3 and 1.1). 
Simonsen (1975) found a reduction in amplitude as a function of duration 
of the diabetes. In 1980 he reported the prognostic value of the reduced 
OPs with respect to the risk of developing proliferative diabetic 
retinopathy. In cases with greatly reduced OPs, he found an increase from 
simple to proliferative diabetic retinopathy within three years. In the 
present study a greatly reduced OP activity of 26% of the normal value 
was estimated for the diabetic group 3 consisting of preproliferative 
diabetic retinopathy patients (table 3-4). This finding can be seen as a 
confirmation of the prognostic value since the preproliferative diabetic 
retinopathy stage is supposed to deteriorate rapidly to a proliferative 
stage (Davis, 1974). Bresnick and Palta (1987a) reported a positive 
relation between the reduction in the summed amplitudes of the OPs and 
fluorescein leakage in the angiograms. No reduction of OPs was found in 
the diabetics without leakage, in contrast to the observations of the 
present study. Based on a longitudinal study the authors compared the 
predictive value of summed OPs to the predictive value of the regression 
models of the ETDRS study group (Bresnick and Palta, 1987b). They 
also found a clear relation between the reduction in amplitudes of the OPs 
and non-proliferative diabetic retinopathy. 
In the present study there was a clear relation and overall fit between the 
OP-power and the retinopathy classification. This fit was statistically 
highly significant. In 1987 Coupland observed a reduction in the summed 
amplitudes of patients without diabetic retinopathy. This study was 
checked with colour photographs but without fluorescein angiographs. 
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Some small lesions such as microaneurysms and small haemorrhages, 
visible by ophthalmoscopy, were permitted in the non-background 
retinopathy group of the Coupland study. In the present study these 
patients would be classified as belonging to group 2. 
In all preceding studies no clear description can be found of a reduction 
of OP activity in patients without any diabetic retinopathy signs. 
Fluorescein angiography is often missing. Furthermore, Kothe, Lovasik 
and Coupland (1989) stated that OP decrease is not easy to prove, as 
variability of the repeated measurement is large under various stimulus 
conditions; 25% in his study. Although the OP-power also has a large 
range, a statistically significant reduction can be established already 
between the normal subjects and the patients of group 1, who have no 
ophthalmoscopic sign of diabetic retinopathy. 
This seems to indicate that the OP-power measurement is a sensitive 
method for registering function reduction in diabetic retinopathy, even at 
a stage at which hardly any anatomic lesion can be observed by 
fluorescein angiography. The p-value for the difference between groups 1 
and 2 is somewhat less than between group 1 versus NS and group 2 
versus 3, which may well be due to the slight dissimilarity in retinopathy 
severity between these two groups. The transition from group 2 to 3 is 
better defined by the criterion of non-perfusion, which explains the more 
pronounced statistical separation of the OP-power values between these 
two stages. Concerning the even more severe stage of group 4, it is well 
known, that the OPs are nearly absent in the proliferative stage of diabetic 
retinopathy (Lawill and O'Connor, 1973; Li et al., 1985). The very low 
estimates for the diabetic group 4, the mean being 6.2 micro-Watt (table 
3-3), are consistent with these earlier observations. 
The dominant frequency has a tendency to decrease with the progression 
of diabetic retinopathy. In some cases the OP-power data were minimal 
as was the case with the patients of group 4, being those with proliferative 
diabetic retinopathy, although it was possible to identify the dominant 
frequency for the OP-power measurement. Even a case which had hardly 
any OP activity left at all could still be included. 
It is important to test the reproducibility of the OP-power, since Kothe et 
al. (1989) found unstable repeated measurements of OPs in several 
conditions of light adaptation. Probably the reproducibility factor needs 
to be looked at more carefully in studies where the OP technique is 
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applied in accordance with the standard ERG protocol of the International 
Standardisation Committee of the ISCEV (1989), or when using 
conditioning flashes. These circumstances are not scotopic but probably 
even photopic (Peachy et al., 1987). Under scotopic conditions the 
reproducibility was stable as was statistically substantiated by the 
Wilcoxon test as well as the paired t-test (reproducibility, chapter 3.3.3). 
Measurement of OP-power under photopic conditions appeared to be less 
than feasible. Often there was not a clear distinct frequency interval 
between the OPs and the foregoing a-wave. The main reason was the 
decrease of the OP frequency from approximately 145Hz scotopically to 
somewhere between 127 and 100Hz photopically. Another reason may 
be that the frequency of the a-wave itself increases. The marked decrease 
of the OP frequency photopically is in accordance with the findings of 
Wachtmeister (1973), Gur and Zeevi (1980). Application of coloured 
stimuli to elicit cone dominated OPs may possibly solve these problems 
(King Smith et al., 1986). 
A comparison with conventional methods of OP recording will be given 
in chapter 4. 
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CHAPTER4 
A COMPARISON BETWEEN 
CONVENTIONAL OP REGISTRATIONS AND 
OP-POWER METHOD 
This chapter consists of two sections; the first deals with a comparison 
between OP-power registration and the conventional technique for visual 
assessments of OP recordings. The second describes the amplitude and 
implicit time measurement of the wavelets OP2 and OP3; it was suggested 
recently that this technique would lead to an improvement in OP 
recordings (Bresnick and Palta, 1987c; Coupland, 1987a). 
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CHAPTER 4, PART 1 
4.1 Visual assessment of the OPs compared to OP-power 
4.1.1 Conventional OP registration 
The assessment of OPs by visual inspection is the conventional method in 
use for clinical interpretation. By recording the OPs it is possible to 
differentiate between disorders of the deep receptoral and the superficial 
postreceptoral retinal layers. In the latter the OPs are lower at an early 
stage. The most common postreceptoral disturbances are those relating to 
retinal circulation. Except in the case of diabetic retinopathy, the OPs 
have usually disappeared or diminished by the time the acute stage of 
venous and arterial occlusions has set in (van Lith, 1980). In advanced 
cases of glaucoma, diffuse uveitis and Behc;et disease, in which medial 
opacities can blur funduscopic examination, the detection of OPs can 
reveal additional information for clinical use (Y onemura and Kawasaki, 
1978; Speros and Price, 1981). The postreceptoral disturbances 
manifested in congenital stationary night blindness with myopia (Volker-
Dieben et al., 1974; Lachapelle et al., 1983) and X-linked juvenile 
retinoschisis (Krill, 1972), are less frequently seen in the ERG laboratory, 
but are sometimes important for the establishing clinical diagnosis. The 
visual assessment of OPs is a clinical method which has proven to be 
adequate enough for the diagnosis of advanced cases. 
This method is still in use in the electrodiagnostic laboratory of the 
Rotterdam Eye Hospital. This gave us the opportunity to compare this 
conventional methodtothe newly developed OP-power technique. 
4.1.2 Visual assessment of the OPs 
The OPs are visually assessed and classified by a colleague, who is 
specialised in visual electrodiagnostics. As shown in the schedule (table 
4-1) four categories can be distinguished. Figure 4-1 shows a single flash 
ERG curve; one for each category. 
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Table 4-1. The four categories of visual assessed OPs. 
category 1: 
well developed OPs - the OPs have a clearly descending limb in each wavelet 
category 2: 
lowered OPs 
category 3: 
- the normally descending limb is running more or less 
horizontally 
just identifiable OPs - the normally descending limb is changed into an 
oblique ascending direction 
category 4: 
absent OPs - the b-wave is smooth without possible identification of 
OPs 
For this assessment and the OP-power calculation the same recordings 
have been applied. 
4.1.3 Comparison ofvisually assessed OPs with the OP-power 
Figure 4-2 gives the mean and range of the OP-power for the four 
categories. As one can derive from the figure, there is a large variation in 
the OP-power especially in the categories 1 and 2. The Pearson 
Correlation Coefficient test shows that both parameters, the visual 
assessment and the OP-power calculation, are related to the severity of 
the diabetic retinopathy. When the OP-power and the visual assessment 
are compared this coefficient (R) equals 0.608 (p=O.OOl), meaning that a 
positive correlation exists between the categories of visually assessed 
OPs and the OP-power levels. The total number (N) of subjects which 
were tested was 108 (27 normal and 81 diabetic subjects). The overall 
relation of the effect of diabetic retinopathy on OP-power is statistically 
significant (p=0.05). The relationship with the stage of the diabetic 
retinopathy is not significant (p=0.19) for the visual assessment. This 
means that the OP-power bears more relation to the stage of diabetic 
retinopathy than is the case in visually assessed OPs. Furthermore, if we 
compare group 1 of the diabetic retinopathy patients with the reference 
group no difference is to be obtained by visual assessment, whereas these 
groups are statistically well-separated by the OP-power (chapter 3.3.2). 
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Fig. 4-1: Single flash ERG curve; 1: well developed OPs; 2: lowered OPs; 3: 
just identifiable OPs; 4: absent OPs 
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Fig. 4-2: The range in four categories of OPs (open bars) and the mean of each 
category ( x ). Horizontal line, category of OPs (table 4-1); vertical 
line, OP-power in microwatts. 
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4.1.4 Discussion 
In 1972, Galloway et al. found reduced OPs by visual inspection at the 
established stage of diabetic retinopathy, but failed to prove the existence 
of a reduction in the non-visible or early stages. This could be due to the 
rather rough technique which was used. It is above all in these early 
stages that the improvements in technique to be found in the present 
study can best be seen, i.e. between the reference group and the first stage 
and even more between categories 1 and 2. A quantitative measure 
obviously improves our capacity to differentiate between the OPs. 
Using visual inspection the impression was that OP2 is the last one to 
disappear as the retinopathy increases. This is in compliance with the 
results described in the second part of this chapter. 
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CHAPTER 4, PART 2 
4.2 Comparison of amplitude and implicit time of OP2 and OP3 
with the op-power 
4.2.1 Introduction 
The OP-power is a measure for the summed OP activity. The summation 
of the OP amplitudes is a generally accepted method for the expression of 
the OP activity in diabetic retinopathy (Algvere, 1968; Miyake and 
Solish, 1978; Brunette and Lafond, 1983; Bresnick et al., 1984 and Arden 
et al., 1986). Recently, however Coupland (1987a) as well as Bresnick 
and Palta (1987a) have considered once again whether the relationship 
between the amplitude reduction of the second OP and the degree of 
diabetic retinopathy is stronger than the relation with the summed 
amplitudes. In this chapter the OP-power, acting as a measure for the 
summed OP activity, will be compared with the amplitude of OP2 and 
OP3 separately. Since the implicit time was the most sensitive parameter 
in detecting early diabetic retinopathy in the study of Okumura (1987), a 
comparison with this component will also be made. 
Since the separate OPs were hard to recognize when the amplitudes were 
substantially reduced in advanced retinopathies, only the results of the 
early diabetic retinopathies belonging to groups 1 and 2 are considered in 
this paragraph. 
4.2 .2 Method 
The diabetic patients are those of groups 1 and 2 as described in chapter 
3. The measurements were carried out on the original FIR filtered 
recording which was made possible by retrieving the original signals 
from a computer disc. This means that the conditions for ERG recording 
and signal processing were identical as performed in chapter 2. 
From the FIR filtered signal the amplitudes were immediately calculated 
on the computer's signal processing program (figure 4-3). The implicit 
times were measured by means of automatic top detection (chapter 2.2.1). 
4.2.3 Amplitudes of0P2 and OP3 
The amplitudes of OP2 demonstrate a large variance ranging from 31 u V 
to 169 uV for the diabetic group and from 43 uV to 194 uV for the 
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Fig. 4-3: Filtered signal (FIR) of normal single flash ERG of 10 J. 2) ampli-
tude of OP2 being 108 uV, 3) amplitude of OP3 being 79 uV. 
Table 4-2. Aplitude of OP2 and OP3 
OP2 OP3 
Diabettic range SD mean N range SD mean 
class. 
Normal 
subjects 43-175 32.8 96.0 27 12-125 29.3 59.3 
Groupl 37-133 26.5 79.9 29 5- 88 24.3 48.1 
Group 2 26-153 30.8 75.8 29 6-113 25.2 42.8 
reference group (table 4-2). This means a considerable overlap in the case 
of both ranges. A similar variability is seen for OP3. 
The bar diagrams of figures 4-4 and 4-5 represent the distribution into 
classes of the amplitudes of OP2 and OP3 for the diabetic groups (1 and 
2) together with those of the reference group. The amplitudes of the OP2 
and OP3 decrease before the appearance of ophthalmoscopical visible 
diabetic retinopathy, but this decrease is less marked than the attenuation 
of the OP-power in the early stage of diabetic retinopathy (see also figure 
3-4). 
The relation between the different OP components, viz. the amplitudes of 
OP2, OP3 and the OP-power, was tested with the non- parametric version 
of the Spearman Rank Correlation test (Glanz 1987). Statistically 
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Fig. 4-4: Distribution in classes of the amplitude OP2 in microvolts. NS = 
normal subjects, Gr.I =diabetic group 1, Gr.II =diabetic group 2. 
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Fig. 4-5: Distribution in classes of the amplitude OP3 in microvolts. NS = 
normal subjects, Gr.I = diabetic group 1, Gr.II = diabetic group 2. 
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significant correlations are to be obtained for the right and left eye 
between OP2 respectively OP3 and the OP-power at the one percent 
significance level. The correlation coefficients are equal at 0.79. This 
value means that the three parameters have a good correlation but are not 
mutually substitutable. Possibly, diabetic retinopathy has a slightly 
different influence on the separate indicators. For this purpose the effect 
of the diabetic classification on the amplitudes of OP2 and OP3 was 
tested with a repeated measurement ANOVA, similar to what was done 
with the OP-power results in chapter 3.3.2. The overall relation between 
the three groups (the reference and the two diabetic groups) and the 
amplitude of OP2 is not statistically significant (p= 0.057). The overall 
relation for the OP3 of the same three groups is slightly better (p=0.039). 
This better relation can be primarily attributed to the difference between 
the reference group and the diabetic group 1 (p= 0.015). However, the 
OP-power remains an even better measure (chapter 3.3.2). 
4.2.4 Implicit time of OP2 and OP3 
Measurement of the implicit times of OP2 and OP3 reveals a slight 
increase for both OPs in relation to early diabetic retinopathy (diabetic 
group 1 and 2). The effect on the implicit time of both OPs is tested with 
the non-parametric Krusal and Wallis one-way ANOV A. The p-value is 
0.003 for the increase in implicit time of OP2 and 0.002 for OP3 
respectively. This increase is highly significant and not surprising in the 
light of the very small standard deviation (SD) (table 4-3). 
The comparison between the effect of the stage of diabetic retinopathy on 
the OP2 and OP3 implicit times and the effect on the OP-power was 
Table 4-3. Implicit time of OP2 and OP3 
OP2 OP3 
Diabetic Mean SD N Mean SD 
class. msec. msec. 
Normal 25.3 1.0 27 31.8 1.1 
subjects 
Group 1 26.3 1.4 29 32.8 1.5 
Group 2 26.6 1.3 29 33.3 1.6 
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tested using a statistical model for multiple regression. The dependent 
variables are the OP-power, the implicit time of OP2 and the implicit 
time of OP3; the independent variable is the degree of diabetic 
retinopathy. Table 4-4 presents the estimates. The value of the Adjusted 
R-square is marginally higher for the implicit time of OP3. The 
significance level for the OP-power remains the best; for all three, 
however, they are highly significant (p << 0.002). 
4.2.5 Discussion 
In 1987a Coupland reported a component specific OP reduction in early 
cases of diabetic retinopathy, from a study which was controlled by 
fundus photography. This paper and that of Bresnick et al. (1987c) raised 
our interest in the separate OP parameters and especially in a comparison 
of them with those of the summed OPs as expressed in the OP-power. The 
aim of this chapter is to compare the outcome of the separate OP 
components with that of the OP-power. The Spearman rank correlation 
coefficient presents a good descending order between the OP-power and 
the amplitudes of the separate OPs. The results of both techniques reflect 
the retinopathy state. However, the effect on the OP-power reduction, is 
more distinct than the effect on the amplitude reduction of the separate 
OPs. The slight increase in the amplitude of OP2 (not statistically 
significant) for the diabetic group 2 may be understood by a shift in 
energy of the OP activity between the separate OPs. This effect was 
recently suggested by Lachapelle (1988), who studied the possible fusion 
of the first and second OP and called this form of OP analysis "intensity 
coding". A higher resistance of the second OP with the other OP wavelets 
already deteriorating is a more probable explanation for the different 
behaviour of this component. This OP resistance has also been put 
forward by Coupland (1987b) and Young et al. (1989) quite recently and 
is highly dependent on stimulus conditions and adaptation levels. 
Especially the light adapted OP components reveal these type of changes 
(Kothe et al., 1989). An explanation for the difference in resistance to the 
retinopathy of the OP components could be that the OPl and OP2 
represent more the cone activity and the OP3 and OP4 the rod activity 
(Coupland, 1987b and Aylward, 1989). From the present experiments it 
appears that the measurement of all the OPs together probably gives a 
better representation of the functional situation than the isolated OP2 or 
OP3 component. The explanation may be that the OPs as registered in the 
present study are predominantly scotopic and the rods are mainly affected 
in early diabetic retinopathy (chapter 3.1.2). 
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Table 4-4. Estimates of regression model 
Implicit OP-power Implicit 
time OP2 time OP3 
Adjusted 
R square 0.17 0.18 0.22 
regression 
coef/group +0.02 -0.32 +0.02 
t value +3.1 -3.6 +3.4 
level of 
signific. < 0.0023 < 0.0005 < 0.0011 
The slight increase in implicit time of the OPs in early diabetic 
retinopathy has already been observed by Y onemura and Kawasaki 
(1979). Later on, this could not be confirmed by other investigators (Carr 
and Siegel, 1982; Coupland, 1987b). Recently Okumura (1987) found 
that an increased implicit time is an earlier symptom than the summed 
amplitude reduction. In the majority of the diabetic patients in his study 
this increase was more distinct for the OPl and OP2 than for the OP3 and 
OP4. In the present study the increase in implicit time is found to be 
statistically significant for OP2 and OP3 as well. The effect on the 
implicit time of OP2 appears to be slightly less significant than the effect 
on the OP-power (table 4-4). As the increase in implicit time is very 
small, it may be difficult to investigate this time difference. A high 
resolution and precise implicit time measurement technique will be 
necessary for the studying of these small differences. Recently 
Kobayashi, Shinzato and Yokoyama (1987) put forward some 
recommendations for arriving at just such an improvement. These authors 
stated that the latency measurement should be performed following 
Fourier transform rather than analog filtering procedures. The latter 
causes a time shift of the entire ERG signal, which is dependent on a- and 
b-wave magnitude. 
In conclusion, it appears that the amplitude measurement provides 
clinical evidence to support the assumption that the second OP is more 
resistent to an increase of diabetic retinopathy. Given that the OPs are 
detected by means of a high resolution technique, the implicit time of the 
OPs seems to be just as discriminative in detecting early diabetic 
retinopathy as the OP-power itself. 
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CHAPTER 5 
GENERAL DISCUSSION ON THE OP-POWER 
MEASUREMENT 
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The name of the thesis "OP-power measurement in diabetic retinopathy" 
suggests the existence of a physical measure for the energy of the OPs. 
As the detailed localisation of the OPs and their origin are not completely 
understood (chapter 1.7), an absolute scientific validation of the OP 
measure can not be presented. The measurement interval as has been 
introduced in chapter 2.2, is more or less arbitrary and the specific OP 
frequencies can always hide some energy produced by the other ERG 
components or artefacts. 
The term "OP-power" was chosen for the energy calculations, since the 
term FFT -magnitude, which is sometimes used in cardiological literature, 
does not refer to the electrical origin but merely to the processing 
procedure of the signal (Cain et al., 1984). 
The aim of the study was to outline the role of the OPs in diagnosing 
diabetic retinopathy and their relation to standard ophthalmological 
methods. As early as 1966 Simonson had already reported on a relation 
between background retinopathy and the disappearence of the OPs. Many 
observations concerning this relation have been published ever since 
(chapter 1.6). The conventional method for OP detection proceeds from 
the individual wavelets by visual assessment of the wavelets or by 
measurement of the amplitudes and sometimes of the implicit times. 
5.1 The single flash OP recording 
As the origin and the properties of the OPs are still matters under 
discussion (chapter 1. 7), it is not surprising that many methods have been 
proposed for the detection of OPs. They differ greatly in their 
specifications for stimulus luminance and stimulus interval. Stimulus 
conditions are usually chosen with an intention to obtaining the largest 
possible OP responses. Wachtmeister recommended a stimulation 
technique, based on her work carried out in 1974 on luminosity functions 
of the OPs. She used a luminance whereby both scotopic and photopic 
functions reach their maximum in the consolidated response 
(Wachtmeister, 1974b). This can also be achieved by applying 
conditional flashes or by a 4Hz flicker (Wachtmeister, 1987). 
The multitude of stimulus techniques makes it difficult to compare 
results. This lead to a recommendation for standardisation by the ISCEV 
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(International Society for Clinical Electrophysiology of Vision). A 
standardisation committee was installed and provided its report in 1989. 
Basing their work principally on Wachtmeister (1987) the committee 
advised an averaged 4 Hz white flash ERG in the dark- adapted state. 
Standardisation increases the possibility of comparing the results between 
various laboratories, but restricts the possibility of adjusting the 
technique to certain pathological conditions. Since in the case of diabetes 
functional loss in the scotopic system is one of the earliest signs of 
retinopathy, specific conditions are required to enhance the rod 
contribution (chapter 3.1.2). Therefore, single flashes in the dark were 
applied and the dark period between the stimuli was increased to three 
minutes. 
Methods to separate cone and rod dominated OPs are still under 
discussion (King Smith et al., 1986). Various clinical entities probably 
determine the stimulus conditions required, which means there will be 
some variation. It is too early yet to make definite choices. 
The availability of a computerised system worked as a favourable 
condition, since this facilitated the conversion of the original ERG signals 
into a digital signal, which can be processed and analysed in various ways 
afterwards (chapter 2). When searching for a quantative measure for the 
OPs, it was sometimes difficult to actually recognize the individual 
wavelets which often lead to conventional measurement techniques 
becoming unreliable. Therefore, it is not surprising that many authors 
have used the summed amplitudes of the individual wavelets as a measure 
for OP activity (chapter 4.2.1). But even then the individual wavelets 
have to be recognized and measured. 
The OP-power method is based on the principle that the separate OP 
wavelets have the same origin (Heynen et al.,1985). This was the latest 
hypothesis in 1986 when the present investigations were started. 
However, just recently some doubts about this assumption have been 
expressed (chapter 5.3). 
The OP-power appeared to reflect the degree of diabetic retinopathy in a 
reasonable way and was better than the earlier methods. For the first time 
abnormal responses could be established before the appearance of an 
ophthalmoscopically visible retinopathy. 
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When later on, changes in the separate wavelets became of interest 
(Bresnick and Palta, 1987c; Coupland, 1987b; Okumura, 1987), the 
digital storage of the original ERG signals made it possible to analyse 
OP2 and OP3 separately. Just by retrieving the original signals, a second 
measurement procedure could be performed (van der Torren et al., 1987; 
chapter 4-2). 
5.2 OPs in the diagnosis and treatment of diabetic retinopathy 
In general OPs are not used to establish a diabetic retinopathy or the 
degree to which it has developed. Ophthalmoscopy and fundus 
photography are usually sufficient except in the early stages (Moss et al., 
1985). Even better than fundus photography is fluorescein angiography 
(Haut et al., 1987). Ophtalmoscopy, fundus photography and fluorescein 
angiography all provide morphological information (Nielsen, 1982). The 
functional state can be examined by standard visual function tests or by 
specific tests such as detailed perimetry (Bell and Feldon, 1984) and 
electrophysiology. Electrophysiological examination became of interest 
after discovering the sensitivity of the OPs for diabetic retinopathy 
(Yonemura et al., 1962; Simonsen, 1966). When fluorescein angiography 
cannot be applied or gives insufficient information OP detection becomes 
all the more important. This is the case in the early stage of diabetic 
retinopathy, in the blurring of the media (cataract) and in the systemic 
side effects of intravenous administration of fluorescein (Yannuzzi et al., 
1986). A disadvantage with OP registration, for clinical purposes as well 
as for scientific studies, was the absence of a reliable and quantitative 
measure. By processing the ERG signal such a measure (OP-power) was 
achieved. 
The OP-power is expressed in a numerical value which allows 
mathematical analysis. This is especially important in scientific 
investigations comparing groups. Unfortunately, the large range of the 
OP-power as recorded makes it difficult to compare individual patients in 
a normal population, which limits its clinical application. Longitudinal 
studies using the same individual are certainly feasible. 
The large scale and reproducibility of OP-power makes this method 
especially applicable in early and/or serious retinopathies where other 
methods fail. As far as the serious retinopathies are concerned, Hennekes 
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and Deschner (1984) reported a possible increase in OP activity following 
extensive laser coagulation treatment. 
The reproducibility was better under scotopic rather than under photopic 
conditions. In this regard the mesopic range as advised to obtain high 
OPs, is a very critical level. Kothe, Lovasik and Coupland (1989) are of 
the opinion that an unstable adaptive level may possibly be the cause of 
the fluctuations they found on repeated measurement. They also mention 
non-uniform retinal illumination and varying electrode impedance as the 
possible causes of the variability in OP amplitudes. In the discussion they 
speculate that fluctuations in dopamine release in response to light 
adaptation may be of influence. Their final conclusion was that implicit 
time measurements are preferable in longitudinal studies. This conclusion 
could not be confirmed in the present study when the OPs are registered 
in the scotopic range (chapter 4.2.4). 
Apart from diabetic retinopathy the OP-power may also be helpful in 
other post-receptoral disturbances for a quantification of the defect. The 
method has already been succesfully applied for tracing carriers of 
congenital stationary night blindness (Young et al.,1989). 
5.3 Neurogenic function in diabetic retinopathy 
Most probably OPs reflect the neuronal activity of the bipolar cells, 
although the interplexiform cell cannot be excluded as a generator 
(Wachtmeister, 1987). They may carry information about the functional 
integrity of the neural elements at the inner retinal layers, while, 
fluorescein angiography and fluorophotometry give information about 
the morphologic changes and the vascular function. There is even 
accumulative evidence that increased permeability, measured by 
fluorophotometry, is one of the earliest detectable changes in diabetic 
retinopathy (Cunha-Vaz, 1981 ). Therefore, it would be interesting to 
compare the fluorophotometry together with the fluoroangiography as 
measures for capillary dysfunction to the OP-power in early diabetic 
retinopathy, in order to find out, whether the neural changes will coincide 
with a dysfunction of the blood retina barrier. Yoshida et al. (1987) has 
already carried out a comparative study between OP measurement and 
fluorophotometry. He concluded that the implicit time of the OPs was 
increased at an early stage of diabetic retinopathy. The implicit time was 
even earlier disturbed than other parameters such as fluorophotometry 
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and OP amplitude. There is a likelihood of the neuronal dysfunction 
being caused by a direct defect in the bipolar cell layer, in the sense that it 
is possibly osmotic, rather than by ischaemia of this cell layer. If this is 
the case vascular dysfunction and neurogenic dysfunction does not have 
to decrease at the same time. The early decrease of OP-power in diabetic 
retinopathy might prove to be an argument in favour of such a theory. 
Another argument pointing in the same direction comes from the 
morphometric analysis of retinal blood vessels in diabetic retinopathy. 
Fuchs et al. (1985) concluded from their study that pericyte loss and 
crude capillary damage cannot be the primary cause of neuronal 
degeneration, since the pericytes disappear at the same time and in the 
same pattern as the other extravasal cells. 
As already mentioned OP-power is based on the principle that the OPs 
originate in the same structure (Heynen, 1985). Later investigators 
propose the reverse namely that it is not the bipolar cells which generate 
the OPs, but that the OPs are generated between the inner and outer 
plexiform layers by synaptic feedback circuits (Yanagida et al., 1988). It 
is even questionable whether the increase in implicit time and the 
decrease in amplitude are caused by the same mechanism, since 
Yonemura and Kawasaki (1979) demonstrated that quinaldic acid affects 
the implicit time of the OPs selectively. This is in accordance with the 
recent finding of Sannita et al. (1988) This author describes a direct effect 
of neurotransmitters as L-acetylcarnitine on the implicit times of the OP2 
component, which is that of causing a significant reduction. He did not 
find statistically significant changes in the amplitude of any of the 
separate OPs. 
This finding could not be confirmed in the present study. In early diabetic 
retinopathy the implicit times of the OP2 and OP3 were delayed at the 
same stage of the disease as that at which the OP-power was decreased. 
The possibility that the second OP is less sensitive to diabetic retinopathy 
may contradict the conclusion that OPs originate in the same structure 
(Heynen et al., 1985). Another argument in favour of the hypothesis is 
that separate OPs do not have the same nature, which can also be deduced 
from the finding of Marmor et al. (1988). He found that especially the 
second OP is selectively suppressed by a D1 antagonist in experiments 
using a rabbit. The present study also indicates a selective resistence of 
OP2 (chapter 4.2.3). The mechanism is still unknown. However, a study 
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in which cone or rod dominated OPs are clearly separated might give the 
answer to the difference in behaviour of OP2 (Coupland, 1987b). 
5.4 Other applications of OP measurement in diabetic retinopathy 
The neural function may be of interest in testing procedures, regarding 
the effectiviness and side effects of new drugs. 
The factor OP-power may prove its value in situations like those in which 
groups of diabetic patients are tested for their reaction to newly developed 
treatment in research protocols. 
Another application may be the predictive value of OP reduction when 
diabetic retinopathy increases towards the proliferative stage. This was 
reported by Simonsen (1975) and Bresnick and Palta (1987b). Even more 
important would be the possibility for identification of the 
preproliferative stage using OP-power. This stage is of special interest 
since it seems to be the most favourable point for starting coagulation 
therapy (Little, 1985). The ETDRS (1987) started a study to investigate 
this matter. 
In our classification system the preproliferative stage is represented by 
group 3. The diagram of figure 5-1 shows a logistic model which 
describes how the diabetic groups 2 and 3 can be distinguished on the 
basis of their OP-power. This model is estimated from the OP-power 
measurement of the left eye of patients in groups 2 and 3. In these patients 
(26 patients in group 2 and 15 patients in group 3) the break-even point is 
at 13.8 microwatt, where the probabilities of belonging to group 2 or to 
group 3 are the same (50%). The chance for getting serious ischaemic 
changes in the retina has to be considered below the 13.8 microwatt level, 
where the probability of belonging to group 3 is larger than the probability 
of belonging to group 2. This may have consequences for the timing of 
the photocoaculation treatment. 
With the development of personal computer technology the costs, for 
special methods like OP-power measurement, will decrease and will 
become in reach of many clinical laboratories. In particular the storage of 
ERG responses has been improving since the memory of the hardware 
has started to expand (Salu et al., 1989). This technical development can 
be used for longitudinal studies in diabetic retinopathy. 
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Fig. 5-l: A logistic model representing the discrimination between groups 2 
and 3; it expresses the probability of belonging to group 3 as a 
function of OP-power. Horizontal line: OP-power in microwatts; 
vertical line: probability(%) of belonging to group 3. 
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SUMMARY AND CONCLUSIONS 
The present study is mainly concerned with the role of the OPs in 
diagnosing early diabetic retinopathy. In 1966 Simonsen had already 
found a clear relation between background diabetic retinopathy and the 
disappearance of OPs at the ascending limb of the b-wave of the ERG. 
Many investigators have studied this relationship ever since, but because 
of a deficiency in a quantification measure of the OPs, the clinical 
application has been unsatisfactory. Recent developments involving 
digitalising of the ERG signal and the accompanying related increase in 
signal processing techniques, nowadays offer us the opportunity of 
developing a reliable system of OP quantification. 
Diabetic retinopathy is characterized by multiple vascular lesions of the 
eye fundus. The clinical course is quite variable, but one or another 
feature may predominate the fundus picture at a given time. The 
knowledge of the pathogenesis in diabetic retinopathy remains 
incomplete as yet; as does the precise cell localisation of OPs and their 
relation to diabetic retinopathy. As long as this knowledge is incomplete 
a classification and measurement system of the retinal function in this 
disease will be defective. 
In chapter 1: a review has been given of the literature containing theories 
concerning the pathogenesis of diabetic retinopathy, as well as the history 
and origin of the electroretinographic features. 
Early salient features in diabetic retinopathy are vasodilatation and 
microaneurisms together with capillary closure. These early changes are 
important as the aim of this study is to identify the role of the small 
wavelets known as oscillatory potentials (OPs) on the ascending b-wave 
of the ERG. 
Chapter 2 concerns the detection methods of the OPs and explains the 
advantages of a digital system above an analog filtering system. 
Sometimes it was difficult to interpret the results of the digitally filtered 
signal. Thereupon, an effort was made to improve the measurement 
method by signal processing. This resulted in a new clinical method in 
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which a digital filter was applied to the single flash 10 J ERG response 
followed by Fast Fourier Transform (FFT). 
The frequencies of the OPs and those of the foregoing a-wave are 
sometimes in the same range. The main problem was their separation. 
The energy of the OPs is calculated by determining the dominant 
frequency around which a floating window specifies the frequency 
domain. The calculated energy is represented by the OP-power and is 
expressed in microwatts. As the digital filter does not cause a phase shift, 
the filtering program can be extended by an automatic top detection in 
order to measure the implicit times and to calculate the amplitudes of the 
OPs. 
In chapter 3 a clinical study is described concerning the OP- power 
measurement in four groups of diabetic patients. The diabetic retinopathy 
varies from a non-visble towards a preproliferative stage. Special 
attention has been paid to the features of diabetic retinopathy group 1. 
The question was at which stage of diabetic retinopathy could 
electrophysiologic abnormalities be detected. The OP-power is measured 
under scotopic conditions. The duration of the stimulus interval has been 
discussed with reference to the literature. The frequency shift to higher 
values when the stimulus interval is increased, positively influences the 
identification of the frequency domain of the OPs. 
The overall effect of diabetic retinopathy on the OP-power is statistically 
highly significant. The decrease in OP-power, when the retinopathy 
group 1 is compared with the reference group, is found to be statistically 
significant as well. From this it may be concluded that using the OP-
power measure diabetic retinopathy can be detected at an early stage. In 
the study, the OP-power method does not provide sufficient information 
under photopic conditions. This may be due to the relatively large 
decrease in the frequency of the OPs in the light adapted state. The OP-
power as applied under scotopic conditions appears to have a stable 
reproducibility, which is in contrast to a recent study by Kothe et al. 
(1989) concerned with OPs under photopic conditions. The dominant 
frequency of the FFT in the domain at which the OP activity is to be 
suspected scotopically, shows a shift to lower frequencies while the stage 
of retinopathy increases to the preproliferative stage. 
In chapter 4-1 a comparison has been made between OP-power recordings 
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and visual assessment of the OPs. The OP-power method revealed a 
better relation with the diabetic retinopathy statistically than did the 
subjective method, although there is a good correlation between the two 
methods. 
In chapter 4-2 a comparison was made between OP-power and the 
amplitude of the separate wavelets OP2 and OP3. The reduction in 
amplitude of the separate OP2 wavelet is not statistically significant. The 
OP3 wavelet, however, provides a "just- significant" reduction, while the 
decrease in OP-power is "highly significant" (p < 0.001). The increase in 
the implicit time of the OP2 and OP3 appears to be significant for the 
diabetic groups 1 and 2. This increase is nearly as effective in reflecting 
the stage of the diabetic retinopathy as the OP-power is. 
Chapter 5 contains a general discussion. A few ideas are formulated to 
achieve the OP-power method in future studies. 
In conclusion, it may be stated that the results of the OP-power method 
show a convincing improvement in the methods for the detection of 
electroretinographic changes in early diabetic retinopathy. The OP-power 
results are better when compared to the conventional techniques as well 
as when compared to the individual results of the wavelets OP2 and OP3. 
The OP-power method substantiates a quantative measure of the OPs 
even in advanced stages of diabetic retinopathy. 
75 
SAMENVATTING EN CONCLUSIE 
Het doel van deze studie is na te gaan welke plaats de Oscillatory 
Potentials (OPs) inneemt als diagnostische onderzoekmethode tussen de 
functieonderzoeken die bij diabetische retinopathie in gebruik zijn. In 
1966 ontdekte Simonsen reeds dater een duidelijke relatie bestaat tussen 
het ontstaan van achtergrond diabetische retinopathie en het verdwijnen 
van de OPs op de stijgende tak van de b-golf in het ERG. Sindsdien zijn 
er vele onderzoekers geweest die zich met deze relatie bezig hebben 
gehouden. Wegens gebrek aan mogelijkheden tot kwantificering van de 
OPs waren de uitkomsten van deze onderzoeken, zeker voor klinische 
toepassing, nog onbevredigend. De recente ontwikkeling in het digitali-
seren van ERG signalen en de daarmee samengaande mogelijkheden tot 
signaalbewerking, stelt ons thans in de gelegenheid om een betrouwbare 
kwantificering van de OPs te ontwikkelen. 
Diabetische retinopathie wordt gekarakteriseerd door multipele 
vasculaire laesies van de fundus, waarvan het klinische beeld sterk 
varieert. Bepaalde verschijningsvormen kunnen echter op een zeker 
tijdstip het beeld domineren. Het mechanisme dat leidt tot de pathogenese 
is nog onvolledig bekend, evenals de oorsprong van de OPs op cellulair 
niveau en hun relatie tot de diabetische retinopathie. Zolang de kennis 
van de pathogenese onvolledig is, zal elk classificatiesysteem en 
functieonderzoek te kort schieten. 
In hoofdstuk 1 worden uit literatuurstudie verkregen theorieen over de 
ontstaanswijze van diabetische retinopathie beschreven. Eveneens wordt 
een historisch overzicht gegeven over het electroretinografisch beeld van 
de diabetische retinopathie en over de oorsprong van de OPs. 
Vasodilatatie en microaneurysmata zijn, samen met capillaire afsluiting, 
de meest opvallende vroege kenmerken. Deze vroege veranderingen zijn 
belangrijk, daar het doel van deze studie is de rol van de OPs in het ERG 
tijdens dit stadium van de ziekte te onderzoeken. 
Hoofdstuk 2 behandelt de detectiemethoden voor OPs en laat de 
voordelen zien van een digitaal boven een analoog filtersysteem. 
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In sommige gevallen was het moeilijk om de resultaten van het digitaal 
gefilterde signaal te interpreteren. Vervolgens werd getracht de 
meetmethode te verbeteren met behulp van signaal bewerking. Dit 
resulteerde in de invoering van een nieuwe klinisch toepasbare 
meetmethode, waarbij de 10 J enkele flits responsie digitaal gefilterd 
werd, gevolgd door Fourier analyse van het gefilterde signaal. 
De frequenties van de OPs en die van de daaraan voorafgaande a-golf 
liggen soms in hetzelfde gebied. Het belangrijkste probleem was deze te 
scheiden. De energie van de OPs wordt berekend door de dominante 
frequentie op te zoeken, waaromheen een variabel venster het 
frequentiegebied aangeeft. De berekende energie wordt weergegeven 
door de OP-power en wordt uitgedrukt in microwatts. Aangezien de 
digitale filter geen fase verschuiving introduceert, kan het 
filterprogramma worden uitgebreid met een automatische top detectie 
teneinde de piek latentie tijden te meten en de amplituden te berekenen. 
In hoofdstuk 3 wordt een klinische studie beschreven betreffende de 
bepaling van de OP-power bij vier groepen diabetes patienten. De diabe-
tische retinopathie van deze patienten varieert tussen een niet zichtbare 
en een preproliferatief stadium. Speciale aandacht werd besteed aan de 
kenmerken van de retinopathie groep 1, om te bepalen in welke fase er 
elektrofysiologische veranderingen kunnen worden waargenomen. 
De OP-power wordt gemeten onder scotopische omstandigheden. De 
duur van het interval tussen de stimuli wordt aan de hand van een 
literatuuroverzicht besproken. De frequentie van de OPs wordt hoger bij 
het toenemen van de interstimulustijd, hetgeen het scheiden van het OP 
frequentiegebied van de a-golffrequenties verbetert. 
Het effect van de diabetische retinopathie als geheel op de OP-power is 
statistisch sterk significant. Het afnemen in OP-power, bij vergelijking 
van de diabetische retinopathie-groep 1 met de referentie-groep, is 
statistisch ook significant. Hieruit kan de conclusie worden getrokken, 
dat met de OP-powermethode de diabetische retinopathie in een vroeg 
stadium kan worden opgespoord. 
De OP-power geeft onder fotopische condities, zoals in deze studie is 
toegepast, niet voldoende informatie. Dit kan een gevolg zijn van de 
sterke frequentiedaling van de OPs bij lichtadaptatie. 
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De OP-power heeft onder de toegepaste scotopische condities een goede 
reproduceerbaarheid, dit in tegenstelling tot de OP bepalingen in de 
recente studie van Kothe en medewerkers (1989) onder fotopische 
condities. 
De dominante frequentie van het frequentiegebied, waarin de OPs 
scotopisch verwacht worden, neemt af bij het toenemen van de retino-
pathie naar een preproliferatief stadium. 
In hoofdstuk 4-1 wordt een vergelijking gemaakt tussen de beschreven 
OP-power en de visuele beoordeling van de OPs. De relatie tussen de OP-
power en de diabetische retinopathie bleek statistisch beter gedefinieerd 
dan die van de visueel beoordelde OPs, ofschoon er een goede correlatie 
bestaat tussen de twee methoden. 
In hoofdstuk 4-2 wordt OP-power vergeleken met de uitkomsten van de 
afzonderlijke amplituden OP2 en OP3. De reductie in amplitude van de 
OP2 is statistisch niet significant. Die van de OP3 is net significant, 
terwijl de afname van de OP-power statistisch sterk significant is (p < 
0.001). Het toenemen van de piek latentie-tijden van de OP2 en de OP3 
blijkt eveneens significant te zijn voor de diabetische retinopathiegroepen 
1 en 2. Deze toename is bijna even effectief in bet weergeven van bet 
groepseffect als de OP-power. 
Hoofdstuk 5 bevat een algemene discussie. Enkele suggesties voor de 
toepassing van de OP-power methode bij toekomstige studies worden er 
gegeven. 
Concluderend kan worden gesteld dat de resultaten van de OP-power 
methode een overtuigende verbetering zijn in de bepaling van de 
elektroretinografische veranderingen bij vroege diabetische retinopathie. 
De resultaten met de OP-power zijn beter in vergelijking met die van de 
bestaande technieken en die van de afzonderlijke amplituden van OP2 en 
OP3. 
De OP-power geeft een kwantitatieve maat aan de OPs, zelfs in 
gevorderde stadia van diabetische retinopathie. 
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NAWOORD 
Het verschijnen van dit proefschrift stelt mij in de gelegenheid enkele 
woorden van dank te richten tot allen die aan de totstandkoming van dit 
proefschrift een bijdrage hebben geleverd. Een aantal van hen wil ik met 
name noemen. 
De medewerking van tientallen patienten en proefpersonen heeft 
uitvoering gegeven aan het onderzoek, aan hen ben ik veel dank 
verschuldigd. 
Prof. Dr. G.H.M. van Lith. Fried jij hebt mij met je grote kennis van de 
klinische elektrofysiologie geinspireerd en bijgestaan met het volbrengen 
van dit proefschrift. Van jouw kritische aantekeningen en de zorgvuldige 
wijze waarop de onderzoeksresultaten werden beoordeeld, heb ik veel 
geleerd. Hiervoor ben ik je nu ook zeer erkentelijk. 
Prof. Dr. A.Th.M. van Balen, Prof. Dr. D. van Norren en Prof. Dr. A.F. 
Casparie, wil ik bedanken voor het kritisch doornemen van mijn 
proefschrift en hun bereidheid zitting te nemen in de promotiecommissie. 
Drs. G. Groeneweg. Bert heeft van het moment van mijn intrede in het 
Merwede ziekenhuis het enthousiasme voor de elektrofysiologie met mij 
gedeeld. Zijn uitstekende kennis van signaalanalyse en computer-
technieken was een onontbeerlijke hulp en steun bij de ontwikkeling van 
het signaal bewerkings programma. 
De statistische bewerking van de gegevens werd verricht door Drs. Paul 
Mulder op de afdeling Biostatistiek van de Eramus Universiteit te 
Rotterdam. Snel en met grote vaardigheid leidde hij de gegevens door de 
diverse testprogramma's. 
De fluorescentie en fundus foto's werden beoordeeld door de oogarts Dr. 
Bettine Polak. Haar bedank ik voor de nuttige aanwijzigingen. 
Mijn vrienden Michael en Janka Koss en AI de Weerd bedank ik voor hun 
suggesties bij het uitwerken van de laatste hoofdstukken. 
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De opstelling van de meetapparatuur werd mede verzorgd door Wilfried 
van Marle van de afdeling elekrofysiologie van het Oogziekenhuis 
Rotterdam. 
De laboratoriumbepalingen werden op de afdeling klinische 
neurofysiologie verricht in het Merwede ziekenhuis door Anja van 
Schelven. Met onvermoeibaar enthousiasme werden alle ERG gegevens 
uitgewerkt en opgeslagen en in sommige gevallen voor verdere 
bewerking opnieuw weer uitgelezen. 
De modificatie van de contactlens kwam tot stand dankzij de inzet van 
Arie Kardol. 
De fundus fotografie en fluorescentie angiografie alsmede de figuren van 
de uitgave werden met grate inzet vervaardigd door Alfons Jannink en 
Bob Schotel. 
Het secretariele werk, waaronder het sorteren van de literatuurlijst en het 
in gereedheid brengen van het manuscript, werd met voortdurend 
enthousiasme verricht door Rieske Troost. 
Marie-Louise van Westen en Ancilla Melcherts zijn een grate steun 
geweest in de organisatie en bij de begeleiding van de proefpersonen. 
Tot slot Anne Lous, wil ik jou met name noemen voor je hulp bij de 
organisatie, het kritisch doorlezen op spel- en stijlfouten en bovenal voor 
het geduld en de stimulans tot aan het passeren van de eindstreep. 
Ook mijn kinderen Ward, Marelise en Anne Perine bedank ik voor hun 
grote tolerantie; ik beloof hun nu eindelijk wat tijd te hebben om eens 
"iets leuks te gaan doen". 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd op 4 september 1948 te Geleen 
geboren. Hij deed eindexamen HBS-B aan het Nederlandsch Lyceum te 
Den Haag in 1968. Aansluitend studeerde hij Geneeskunde aan de Rijks-
universiteit te Leiden. Van 1970 tot 1972 was hij werkzaam als student-
assistent op het Laboratorium voor Stollings Physiologie onder leiding 
van wijlen Dr. J.J. Veltkamp. 
In 197 5 werd het artsexamen behaald. 
De militaire dienst werd in de periode 1975/1976 vervuld op de afdeling 
oogheelkunde van het Militair Hospitaal te Utrecht. 
Op 1 oktober 1976 began hij zijn opleiding tot oogarts in het Oogzie-
kenhuis te Rotterdam (opleider: Prof. Dr. H.E. Henkes). Op 1 oktober 
1980 werd hij ingeschreven in het Specialisten Register als oogarts. 
Sinds juli 1981 is hij als oogarts verbonden aan het Merwede Ziekenhuis 
te Dordrecht, alwaar hij sinds 1986 het onderzoek beschreven in dit 
proefschrift heeft verricht onder leiding van Prof. Dr. G.H.M. van Lith. 
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